Indicate by check mark whether the issuer (1) filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of ~~February 11,~~August 12, 2022, there were ~~115,526,404~~ 116,961,005shares of $0.001 par value Common Stock outstanding.

	December 31, 2021			March 31, 2021			June 30, 2022			March 31, 2022
	(Unaudited)						(Unaudited)
ASSETS
Current Assets:
Cash and cash equivalents	$	27,414,571		$	118,341,471		$	20,901,109		$	23,281,475
Accounts receivable, net		45,653,542			8,993,920			38,997,537			43,955,084
Due from related parties		15,657			15,657			1,559,000			15,000
Inventories		46,466,594			15,866,918			64,588,248			59,016,152
Prepaid expenses		3,923,778			2,402,366			4,576,824			3,423,925
Current portion of restricted cash								500,000			-
Total Current Assets		123,474,142			145,620,332			131,122,718			129,691,636

Equipment, net		32,368,131			21,553,226			46,669,664			37,637,806

Other Assets:
Deposits		15,585,668			1,833,429			11,829,304			11,360,322
Licensing agreements, net		4,167			41,667
Restricted cash, net of current portion								500,000			-
Patents, net		5,649,562			6,019,567			5,402,852			5,526,218
Other intangible assets, net		139,652,716			2,220,958			133,156,993			136,300,387
Goodwill		90,870,094			-			90,870,094			90,870,094
Right of use assets - operating leases		2,707,546			2,090,162
Deferred income tax asset		892,258			-
Right of use assets – operating leases								2,583,344			2,791,850
TOTAL ASSETS	$	411,204,284		$	179,379,341		$	422,134,969		$	414,178,313

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	24,425,343		$	4,371,974		$	23,807,732		$	26,817,083
Factoring liability		4,097,867			1,842,188			228,026			485,671
Accrued liabilities		5,114,768			3,462,785			7,012,674			6,178,814
Inventory credit facility		194,810			1,091,098			92,332			825,675
Current portion of operating lease liability		825,343			663,784			811,139			831,429
Current portion of note payable related party		669,463			625,147			700,507			684,639
Current portion of construction note								200,133
Insurance premium note payable		285,718			41,517			1,501,846			-
Total Current Liabilities		35,613,312			12,098,493			34,354,389			35,823,311

Long-term Liabilities:
Contingent consideration payable		227,139			589,892			202,840			204,142
Notes payable related party, net of current portion		358,263			865,771			-			181,132
Note payable		-			4,000,000
Construction note payable, net of unamortized issuance costs		18,905			-			5,634,368			38,330
Operating lease liability, net of current portion		2,006,707			1,477,656			1,900,559			2,091,351
Deferred income tax liability		1,850,277			-			2,037,445			1,536,481
Total Liabilities		40,074,603			19,031,812			44,129,601			39,874,747

Shareholders’ Equity:
Series A Cumulative Perpetual Preferred Stock 8.75%, ($25.00 per share, $0.001 par value) 1,400,000 shares issued and outstanding as of December 31, 2021		1,400			-
Common stock, $0.001 par value, 200,000,000 shares authorized 115,436,404 and 93,099,067 shares issued and outstanding at December 31, 2021 and March 31, 2021, respectively		115,437			93,100
Series A cumulative perpetual preferred Stock 8.75%, ($25.00 per share, $0.001 par value) 1,400,000 shares issued and outstanding as of June 30, 2022 and March 31, 2022, respectively								1,400			1,400
Common stock, $0.001 par value, 200,000,000 shares authorized 116,923,884 and 116,485,747 shares issued and outstanding at June 30, 2022 and March 31, 2022, respectively								116,924			116,487
Additional paid-in capital		382,015,310			202,073,968			386,648,901			385,426,431
Accumulated deficit		(11,002,466	)		(41,819,539	)		(8,761,857	)		(11,240,752	)
Total Shareholders’ Equity		371,129,681			160,347,529			378,005,368			374,303,566
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	411,204,284		$	179,379,341		$	422,134,969		$	414,178,313

The accompanying notes are an integral part of these condensed consolidated financial statements.

													2022			2021
	For the Three Months Ended December 31,						For the Nine Months Ended December 31,						For the Three Months Ended June 30,
	2021			2020			2021			2020			2022			2021

Net Revenues
Ammunition sales	$	44,069,473		$	12,834,490		$	112,629,655		$	27,987,438		$	40,969,883		$	28,351,780
Marketplace revenue		17,596,769			-			46,646,051			-			16,504,946			12,272,066
Casing sales		3,022,944			3,785,754			10,891,897			10,305,648			3,281,197			3,852,486
Total Revenues		64,689,186			16,620,244			170,167,603			38,293,086			60,756,026			44,476,332

Cost of Revenues		42,166,320			13,278,338			102,457,775			32,590,149			42,620,364			25,505,438
Gross Profit		22,522,866			3,341,906			67,709,828			5,702,937			18,135,662			18,970,894

Operating Expenses
Selling and marketing		1,510,574			542,271			4,226,817			1,244,323			1,908,170			1,165,849
Corporate general and administrative		3,737,455			1,639,052			10,976,288			3,805,230			5,029,297			3,156,597
Employee salaries and related expenses		2,939,095			1,172,765			7,943,076			3,329,511			2,785,098			2,356,873
Depreciation and amortization expense		3,725,921			416,625			10,044,994			1,242,809			3,350,356			2,611,061
Loss on purchase		-			-			-			1,000,000
Total operating expenses		11,913,045			3,770,713			33,191,175			10,621,873			13,072,921			9,290,380
Income/(Loss) from Operations		10,609,821			(428,807	)		34,518,653			(4,918,936	)
Income from Operations														5,062,741			9,680,514

Other Expenses
Other income		363			461,000			21,788			274,400			193,498			21,425
Interest expense		(190,319	)		(1,938,630	)		(468,404	)		(2,704,315	)		(120,487	)		(165,279	)
Total other expenses		(189,956	)		(1,477,630	)		(446,616	)		(2,429,915	)
Total other income/(expense)														73,011			(143,854	)

Income/(Loss) before Income Taxes		10,419,865			(1,906,437	)		34,072,037			(7,348,851	)
Income before Income Taxes														5,135,752			9,536,660

Provision for Income Taxes		1,351,998			-			1,351,998			-			1,882,725			-

Net Income/(Loss)		9,067,867			(1,906,437	)		32,720,039			(7,348,851	)
Net Income														3,253,027			9,536,660

Preferred Stock Dividend		(782,582	)		-			(1,902,966	)		-			(774,132	)		(337,745	)

Net Income/(Loss) Attributable to Common Stock Shareholders	$	8,285,285		$	(1,906,437	)	$	30,817,073		$	(7,348,851	)
Net Income Attributable to Common Stock Shareholders													$	2,478,895		$	9,198,915

Net Income/(Loss) per share
Net Income per share
Basic	$	0.07		$	(0.04	)	$	0.28		$	(0.15	)	$	0.02		$	0.09
Diluted	$	0.07		$	(0.04	)	$	0.27		$	(0.15	)	$	0.02		$	0.08

Weighted average number of shares outstanding
Basic		114,757,014			47,790,105			111,289,024			47,023,094			116,560,372			105,876,867
Diluted		116,717,500			47,790,105			113,350,998			47,023,094			117,879,639			109,051,682

The accompanying notes are an integral part of these condensed consolidated financial statements.

For the Three ~~and Nine~~ Months Ended ~~December 31,~~June 30, 2022 and 2021 ~~and 2020~~

The accompanying notes are an integral part of these condensed consolidated financial statements.

							2022			2021
							For the Three Months Ended June 30,
	For the Nine Months Ended December 31,						2022			2021
	2021			2020
Cash flows from operating activities:
Net Income/(Loss)	$	32,720,039		$	(7,348,851	)
Adjustments to reconcile Net Loss to Net Cash used in operations:
Net Income								3,253,027			9,536,660
Adjustments to reconcile Net Income to Net Cash provided by operations:
Depreciation and amortization		12,778,103			3,588,966			4,300,123			3,516,851
Debt discount amortization		18,905			325,141			20,813			-
Employee stock awards		2,898,250			716,589			1,175,063			699,500
Stock grants		197,110			213,130			47,844			66,914
Stock for services		4,200			87,500
Contingent consideration payable fair value		(362,753	)		(88,106	)		(1,302	)		(56,638	)
Allowance for doubtful accounts		1,097,985			54,846			711,372			71,157
(Gain)/loss on disposal of assets		(12,044	)		25,400
Gain on disposal of assets								-			(12,044	)
Reduction in right of use asset		496,469			322,970			208,506			27,087
Warrant issued for services		148,508			-
Deferred income taxes		958,019			-			500,964			-
Stock issued in lieu of cash payments		-			48,000
Interest on convertible promissory notes		-			146,104
Paycheck protection program note forgiveness		-			(624,600	)
Loss on Jagemann Munition Components		-			1,000,000
Stock and warrants for note conversion		-			1,315,494
Changes in Current Assets and Liabilities
Accounts receivable		(20,755,245	)		(3,927,054	)		4,246,175			2,124,556
Due to (from) related parties		-			150
Due from related parties								(1,544,000	)		-
Inventories		(30,599,676	)		(5,140,518	)		(5,572,096	)		(12,072,607	)
Prepaid expenses		1,569,928			16,985			882,620			1,114,473
Deposits		(13,051,850	)		164,388			(493,982	)		(3,119,492	)
Accounts payable		7,538,451			1,842,472			(3,009,351	)		7,021,584
Accrued liabilities		1,310,641			2,332,819			697,799			(208,131	)
Operating lease liability		(514,872	)		(322,037	)		(211,082	)		(39,203	)
Net cash used in operating activities		(3,559,832	)		(5,250,212	)
Net cash provided by operating activities								5,212,493			8,670,667

Cash flows from investing activities:
Purchase of equipment								(5,264,863	)		(1,611,316	)
Gemini acquisition		(50,517,840	)		-			-			(50,651,444	)
Purchase of equipment		(12,868,156	)		(4,493,051	)
Proceeds from disposal of assets		59,800			-			-			59,800
Net cash used in investing activities		(63,326,196	)		(4,493,051	)		(5,264,863	)		(52,202,960	)

Cash flow from financing activities:
Payments on inventory facility, net		(896,287	)		2,250,000			(733,343	)		(832,143	)
Proceeds from factoring liability		86,465,962			26,079,000			24,700,000			23,651,000
Payments on factoring liability		(84,210,284	)		(25,794,381	)		(24,957,645	)		(24,397,199	)
Payments on note payable – related party								(165,264	)		(150,775	)
Payments on insurance premium note payment								(533,673	)		(415,003	)
Proceeds from construction note payable								1,000,000
Preferred stock dividends paid								(638,071	)		-
Payments on assumed debt from Gemini		(50,000,000	)		-			-			(50,000,000	)
Payments on note payable - related party		(463,192	)		(7,235,312	)
Payments on insurance premium note payment		(1,922,651	)		(452,471	)
Payments on note payable		(4,000,000	)		-			-			(4,000,000	)
Proceeds from paycheck protection program notes		-			1,051,985
Proceeds from note payable related party issued		-			3,500,000
Proceeds from note payable		-			4,000,000
Proceeds from convertible promissory notes		-			1,959,000
Sale of preferred stock		35,000,000			-			-			35,000,000
Sale of common stock		-			23,564,619
Common stock issued for exercised warrants		943,907			2,288,878			-			477,811
Stock issuance costs		(3,199,922	)		(3,344,436	)
Preferred stock dividends paid		(1,758,405	)		-
Net cash used in/(provided by) financing activities		(24,040,872	)		27,866,882
Common stock issuance costs								-			(3,170,422	)
Net cash used in financing activities								(1,327,996	)		(23,836,731	)

Net increase/(decrease) in cash		(90,926,900	)		18,123,619
Net decrease in cash								(1,380,366	)		(67,369,024	)
Cash, beginning of period		118,341,471			884,274			23,281,475			118,341,471
Cash, end of period	$	27,414,571		$	19,007,893
Cash and restricted cash, end of period							$	21,901,109		$	50,972,447

The accompanying notes are an integral part of these condensed consolidated financial statements.

We were formed under the name Retrospettiva, Inc. in November 1990 to manufacture and import textile products, including both finished garments and fabrics. We were inactive until the following series of events in December 2016 and March 2017.

On December 15, 2016, the Company’s majority shareholders sold their common stock to Mr. Fred W. Wagenhals (“Mr. Wagenhals”) resulting in a change in control of the Company. Mr. Wagenhals was appointed as sole officer and the sole member of the Company’s Board of Directors.

The Company also approved (i) doing business in the name AMMO, Inc., (ii) a change to the Company’s OTC trading symbol to POWW, (iii) an agreement and plan of merger to re-domicile and change the Company’s state of incorporation from California to Delaware, and (iv) a 1-for-25 reverse stock split of the issued and outstanding shares of the common stock of the Company. These transactions were effective as of December 30, 2016.

On March 17, 2017, the Company entered into a definitive agreement with AMMO, Inc. a Delaware Corporation (PRIVCO) under which the Company acquired all of the outstanding shares of common stock of (PRIVCO). (PRIVCO) subsequently changes its name to AMMO Munitions, Inc.

The accompanying unaudited condensed consolidated financial statements and related disclosures included in this Quarterly Report on Form 10-Q have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and reflect all adjustments, which consist solely of normal recurring adjustments, needed to fairly present the financial results for these periods. Additionally, these condensed consolidated financial statements and related disclosures are presented pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).

The accompanying condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures contained in the Company’s Annual Report filed with the SEC on Form 10-K for the year ended March 31, ~~2021.~~2022. The results for the three ~~and nine~~ month ~~periods~~period ended ~~December 31, 2021~~June 30, 2022 are not necessarily indicative of the results that may be expected for the entire fiscal year. Accordingly, certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to the rules and regulations of the SEC. In the opinion of management, all adjustments have been made, which consist only of normal recurring adjustments necessary for a fair statement of (a) the results of operations for the three ~~and nine~~ month periods ended ~~December 31,~~June 30, 2022 and 2021, ~~and 2020,~~ (b) the financial position at ~~December 31, 2021,~~June 30, 2022, and (c) cash flows for the ~~nine~~three month periods ended ~~December 31, 2021~~June 30, 2022 and ~~2020.~~2021.

We use the accrual basis of accounting and U.S. GAAP and all amounts are expressed in U.S. dollars. The Company has a fiscal year-end of March 31^st.

Unless the context otherwise requires, all references to “Ammo”, “we”, “us”, “our,” or the “Company” are to AMMO, Inc., a Delaware corporation, and its consolidated subsidiaries.

The condensed consolidated financial statements include the accounts of AMMO, Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the condensed consolidated financial statements include the valuation of allowances for doubtful accounts, valuation of deferred tax assets, inventories, useful lives of assets, goodwill, intangible assets, stock-based compensation and warrant-based compensation.

Our accounts receivable represents amounts due from customers for products sold and include an allowance for uncollectible accounts which is estimated based on the aging of the accounts receivable and specific identification of uncollectible accounts. At ~~December 31, 2021~~June 30, 2022 and March 31, ~~2021,~~2022, we reserved $~~1,240,271~~3,766,624 and $~~148,540~~3,055,252, respectively, of allowance for doubtful accounts.

We consider cash to be restricted when withdrawal or general use is legally restricted. Our restricted cash balance is comprised of cash on deposit with banks to secure the Construction Note Payable as discussed in Note 11. We report restricted cash in the Consolidated Balance Sheets as current or non-current classification based on the expected duration of the restriction.

We are a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, ~~(“JJF”),~~LLC, a Texas limited liability company. The license agreement grants us the exclusive worldwide rights through ~~October 15, 2021~~April 12, 2026 to Mr. James’ image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. We agreed to pay Mr. James ~~royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.~~

We are a party to a license agreement with Jeff Rann, a well-known wild game hunter and spokesman for the firearm and ammunition industries. The license agreement grants us through February 2022 the exclusive worldwide rights to Mr. Rann’s image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of all Jeff Rann Branded Products. We agreed to pay Mr. Rann royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

On September 28, 2017, AMMO Technologies Inc. (“ATI”), an Arizona corporation, which is 100% owned by us, merged with Hallam, Inc, a Texas corporation, with ATI being the survivor. The primary asset of Hallam, Inc. was an exclusive license to produce projectiles and ammunition using the Hybrid Luminescence Ammunition Technology under patent U.S. 8,402,896 B1 with a publication date of March 26, 2013 owned by the University of Louisiana at Lafayette. The license was formally amended and assigned to AMMO Technologies Inc. pursuant to an Assignment and First Amendment to Exclusive License Agreement. Assumption Agreement dated to be effective as of August 22, 2017, the Merger closing date. This asset will be amortized from September 2017, the first full month of the acquired rights, through October 29, 2028.

Under the terms of the Exclusive License Agreement, the Company is obligated to pay a quarterly royalty to the patent holder, based on a $0.01 per unit basis for each round of ammunition sold that incorporates this patented technology through October 29, 2028. For the ~~nine~~three months ended ~~December 31,~~June 30, 2022 and 2021, ~~and 2020,~~ the Company recognized royalty expenses of $~~18,558~~44,044 and $~~70,793~~3,404, respectively under this agreement.

On October 5, 2018, we completed the acquisition of SW Kenetics Inc. ATI succeeded all of the assets of SW Kenetics, Inc. and assumed all of the liabilities.

The primary asset of SW Kenetics Inc. was a pending patent for modular projectiles. All rights to patent pending application were assigned and transferred to AMMO Technologies, Inc. pursuant to Intellectual Property Rights Agreement on September 27, 2018.

We intend to continue building our patent portfolio to protect our proprietary technologies and processes, and will file new applications where appropriate to preserve our rights to manufacture and sell our branded lines of ammunition.

On March 15, 2019, Enlight Group II, LLC d/b/a Jagemann Munition Components, a wholly owned subsidiary of AMMO, Inc., completed its acquisition of assets of Jagemann Stamping Company’s ammunition casing manufacturing and sales operations pursuant to the terms of the Amended and Restated Asset Purchase Agreement. The intangible assets acquired include a tradename, customer relationships, and intellectual property.

On April 30, 2021, we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company and Gemini Direct Investments, LLC, a Nevada limited liability company. Whereby SpeedLight Group I, LLC merged with and into Gemini Direct Investments, LLC, with SpeedLight Group I, LLC surviving the merger as a wholly owned subsidiary of the Company. At the time of the Merger, Gemini Direct Investments, LLC had nine (9) subsidiaries, all of which are related to Gemini’s ownership of ~~Gunbroker.com,~~GunBroker.com, an online auction marketplace dedicated to firearms, hunting, shooting, and related products. The intangible assets acquired include a tradename, customer relationships, intellectual property, software and domain names.

We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. ~~NaN~~No impairment expense was recognized for the three and nine months ended ~~December 31, 2021~~June 30, 2022 and ~~2020.~~2021.

We generate revenue from the production and sale of ammunition, and marketplace fee revenue, which includes auction revenue, payment processing revenue, and shipping income. We recognize revenue according to Accounting Standard Codification - Revenue from Contract with Customers (“ASC 606”). When the customer obtains control over the promised goods or services, we record revenue in the amount of consideration that we can expect to receive in exchange for those goods and services. We apply the following five-step model to determine revenue recognition:

We only apply the five-step model when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services it transfers to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations, and assess whether each promised good or service is distinct. Our contracts contain a single performance obligation and the entire transaction price is allocated to the single performance obligation. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly, we recognize revenues (net) when the customer obtains control of our product, which typically occurs upon shipment of the product or the performance of the service. In the year ended March 31, 2021, we began accepting contract liabilities or deferred revenue. We included Deferred Revenue in our Accrued Liabilities. We will recognize revenue when the performance obligation is met.

For the three ~~and nine~~ months ended ~~December 31, 2021,~~June 30, 2022, the Company’s customers that comprised more than ten percent (10%) of total revenues and accounts receivable were as follows:

	Revenues at December 31, 2021					Accounts Receivable						Revenues at June 30, 2022			Accounts Receivable
PERCENTAGES	Three Months Ended		Nine Months Ended			December 31, 2021			March 31, 2021			Three Months Ended			June 30, 2022			March 31, 2022

Customers:
A		-		12.2	%		-			-			10.6	%		-			11.8	%
B		-		-			11.2	%					-			14.5	%		-
C		-		-			18.9	%
D		-		-			-			11.9	%
E		-		-						23.3	%
F		-		-						10.6	%
		-		12.2	%		30.1	%		45.8	%		10.6	%		14.5	%		11.8	%

The following table represent a disaggregation of revenue from customers by category. We attribute net sales to categories by product or services types; ammunition, ammunition casings, and marketplace fees. ~~The Company notes~~We note that revenue recognition processes are consistent between product and service type, however, the amount, timing and uncertainty of revenue and cash flows may vary by each product type due to the customers of each product and service type.

Ammunition products are sold through “Big Box” retailers, manufacturers, local ammunition stores, and shooting range operators. We also sell directly to customers online. In contrast, our ammunition casings products are sold to manufacturers. Marketplace fees are generated through our ~~Gunbroker.com~~GunBroker.com online auction marketplace.

We expense advertising costs as they are incurred in selling and marketing expenses of operating expenses. Marketplace advertising costs are expenses as they are incurred in cost of revenues. We incurred advertising expenses of $~~276,742~~550,447 and $~~448,368~~116,433 for the three ~~and nine~~ months ended ~~December 31,~~June 30, 2022 and 2021, respectively, recognized in selling and ~~we incurred advertising~~marketing expenses ofand $~~51,700~~182,104 and $~~190,277~~ ~~for the three and nine months ended December 31, 2020, recognized in selling expenses and $102,042, and $193,753~~19,000 of marketplace advertising expenses recognized in cost of revenues for the three ~~and nine~~ months ended ~~December 31, 2021.~~June 30, 2022 and 2021, respectively.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of June 30, 2022. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair value. These financial instruments include cash, accounts receivable, accounts payable, and amounts due to related parties. Fair values were assumed to approximate carrying values because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand.

We state inventories at the lower of cost or net realizable value. We determine cost using the average cost method. Our inventory consists of raw materials, work in progress, and finished goods. Cost of inventory includes cost of parts, labor, quality control, and all other costs incurred to bring our inventories to condition ready to be sold. We periodically evaluate and adjust inventories for obsolescence. These provisions are based on our best estimates. At December 31, 2021, and March 31, 2021, we conducted a full analysis of inventory on hand and expensed all inventory not currently in use, or for which there was no future demand.

We state property and equipment at cost, less accumulated depreciation. We capitalize major renewals and improvements, while we charge minor replacements, maintenance, and repairs to current operations. We compute depreciation by applying the straight-line method over estimated useful lives, which are generally five to ten years.

We accrue a liability for compensated absences in accordance with Accounting Standards Codifications 710 – Compensation – General (“ASC 710”).

To date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through our cost of products sold, as this work was done by the same employees who produced the finished product. We anticipate that it may become necessary to reclassify research and development costs into our operating expenditures for reporting purposes as we begin to develop new technologies and lines of ammunition.

~~We accrue a liability for compensated absences in accordance with Accounting Standards Codifications 710 – Compensation – General (“ASC 710”)~~.

We account for stock-based compensation at fair value in accordance with Accounting Standards Codification 718 – Compensation – Stock Compensation (“ASC 718”). which requires the measurement and recognition of compensation expense for all share-based payment awards to employees and directors. Stock-based compensation is recognized on a straight line basis over the vesting periods and forfeitures are recognized in the periods they occur. There were ~~301,250~~ 338,375and ~~856,000~~ 202,500shares of common stock issued to employees, members of the Board of Directors, and members of our advisory committee for services during the three ~~and nine~~ months ended ~~December 31,~~June 30, 2022 and 2021, respectively. ~~There were~~ ~~137,916~~ ~~and~~ ~~465,081~~ ~~shares of common stock issued to employees, members of the Board of Directors, and members of the Advisory Committee for services during the three and nine ended December 31, 2020, respectively.~~

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of December 31, 2021. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair value. These financial instruments include cash, accounts receivable, accounts payable, and amounts due to related parties. Fair values were assumed to approximate carrying values because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand.

Accounts at banks are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of ~~December 31, 2021,~~June 30, 2022, our bank account balances exceeded federally insured limits.

We file federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized. We reflect changes in recognition or measurement in the period in which the change in judgment occurs.

As a result of regulations imposed by the Federal Government for sales of ammunition to non-government U.S. entities, we charge and collect an ~~11%~~11% excise tax for all products sold into these channels. During the three months ended ~~December 31,~~June 30, 2022 and 2021, ~~and 2020,~~ we recognized approximately $~~4.0~~3.7 million and $~~1.2~~ ~~million respectively, in excise taxes. During the nine months ended December 31, 2021 and 2020, we recognized approximately $10.3~~ ~~million and $2.7~~2.4 million respectively, in excise taxes. For ease in selling to commercial markets, excise tax is included in our unit price for the products sold. We record this through net sales and expense the offsetting tax expense to cost of goods sold.

Certain conditions may exist as of the date the condensed consolidated financial statements are issued that may result in a loss to us but will only be resolved when one or more future events occur or fail to occur. We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims and the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability is reasonably estimated, the estimated liability would be accrued in our condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed. On September 24, 2019, the Company received notice that a former employee that had voluntarily terminated filed a complaint against the Company, and certain individuals, with the U.S. Department of Labor (“DOL”). The Complaint in alleges that the individual reported potential violations of SEC rules and regulations by management and that as a result of such disclosures, the individual experienced a hostile work environment; that the Company lacks sufficient internal controls, and that the individual was the victim of retaliation and constructive discharge after being removed as a director by majority vote of the shareholders. The claims were investigated by a newly appointed Special Investigative Committee made up of independent directors represented by special independent legal counsel. The Special Investigative Committee and legal counsel found the material claims were unsubstantiated, including those concerning alleged SEC violations, and recommended enhancements to certain corporate governance charter documents and processes which the Company promptly implemented. The ~~matter is currently~~Parties participated in a successful mediation at the ~~subject~~end of ~~administrative investigation~~June 2022 and all matters relating to this former employee/claimant were confidentially resolved with the lawsuit dismissed with prejudice (Order pending). The settlement was covered by ~~the DOL via the Occupational Safety~~our Employment Practices Liability Policy and ~~Health Administration. The Company~~didn’t amount to a material amount. On February 10, 2022, AMMO filed a ~~timely Position Statement with~~Texas state court complaint against Expansion Industries pursing eight (8) claims in pursuit of recovery of AMMO’s in primer acquisition deposit monies (i.e. Breach of Contract, Common Law Fraud, Violations of Texas Theft Liability Act, Conversion, Negligent Misrepresentation, Unjust Enrichment, Money Had and Received and Constructive Trust). AMMO has since moved aggressively to further the ~~DOL~~process, including successfully garnishing a portion of the deposit monies in ~~October of 2019 in response~~Expansion bank accounts, filing a Motion for Summary Judgement, continuing to ~~the Complaint. The Company received a Due Process letter on January 13, 2022~~pursue written discovery, and ~~responded as directed with supplemental analysis on February 1, 2022. The Company disputes the allegations of wrongdoing and believes the matters raised in~~amending the Complaint ~~are without merit and therefore has and~~to add Expansion principal as an individual party. Discovery continues at this date while the Company awaits the ruling on its Motion for Summary Judgment. AMMO will continue to move forward aggressively ~~defend its interests in this matter. On February 4, 2020,~~with the ~~Company filed suit against a former employee for violating merger agreements with SW Kenetics, Inc., employment agreements, and by unlawfully retaining property belonging~~claims to recover the Company following their termination. On March 11, 2020, the former employee filed a counterclaim against the Company citing breach of contract, breach of implied covenant of good faith and fair dealing, unjust enrichment, and declaratory judgement. The matter was resolved in a confidential manner on or about December 12, 2021. The Company retrieved the unlawfully removed assets, obtained a full release of all claims arising in the subject lawsuit and that might arise in the future relating to contingent consideration the former employee might have been entitled to in the future, subject to certain sales targets being achieved. The lawsuit was dismissed with prejudice, all parties bearing their own fees and costs.deposit monies. There were no other known contingencies at ~~December 31, 2021.~~June 30, 2022.

We calculate basic ~~income/(loss)~~income per share using the weighted-average number of shares of common stock outstanding during each reporting period. Diluted loss per share includes potentially dilutive securities, such as outstanding options and warrants. We use the treasury stock method, in the determination of dilutive shares outstanding during each reporting period. We have issued warrants to purchase ~~2,933,755~~ 2,833,755shares of common stock. Due to the loss from operations in the three and nine months ended December 31, 2020, there are no common shares added to calculate the dilutive loss per share for that period as the effect would be antidilutive. The Company excluded warrants of 150,000 for the three months ended ~~December 31, 2021 and warrants of~~ ~~8,910,205~~ ~~and~~ ~~8,629,432~~ ~~for the three and nine months ended December 31, 2020, respectively,~~June 30, 2022, from the weighted average diluted common shares outstanding because their inclusion would have been antidilutive.

At ~~December 31, 2021~~June 30, 2022 and March 31, ~~2021,~~2022, the inventory balances are composed of:

	December 31, 2021		March 31, 2021		June 30, 2022		March 31, 2022
Finished product	$	3,948,574	$	899,266	$	11,906,050	$	6,167,318
Raw materials		26,307,975		12,440,548		32,918,290		33,924,813
Work in process		16,210,045		2,527,104		19,763,908		18,924,021
Inventory net	$	46,466,594	$	15,866,918	$	64,588,248	$	59,016,152

We state equipment at historical cost less accumulated depreciation. We compute depreciation using the straight-line method at rates intended to depreciate the cost of assets over their estimated useful lives, which are generally five to ten ~~years~~.years. Upon retirement or sale of property and equipment, we remove the cost of the disposed assets and related accumulated depreciation from the accounts and any resulting gain or loss is credited or charged to other income. We charge expenditures for normal repairs and maintenance to expense as incurred.

We capitalize additions and expenditures for improving or rebuilding existing assets that extend the useful life. Leasehold improvements made either at the inception of the lease or during the lease term are amortized over the shorter of their economic lives or the lease term including any renewals that are reasonably assured.

Equipment consisted of the following at ~~December 31, 2021~~June 30, 2022 and March 31, ~~2021:~~2022:

	December 31, 2021			March 31, 2021			June 30, 2022			March 31, 2022
Construction in progress	$	9,282,292		$	544,939		$	22,564,493		$	14,335,371
Leasehold Improvements		257,009			126,558			257,009			257,009
Furniture and Fixtures		331,490			87,790			343,014			343,014
Vehicles		153,254			142,691			153,254			153,254
Equipment		31,238,627			26,425,221			34,360,949			32,524,850
Tooling		143,710			121,790			143,710			143,710
Total property and equipment	$	41,406,382		$	27,448,989		$	57,822,429		$	47,757,208
Less accumulated depreciation		(9,038,251	)		(5,895,763	)		(11,152,765	)		(10,119,402	)
Net equipment	$	32,368,131		$	21,553,226		$	46,669,664		$	37,637,806

Depreciation Expense for the three ~~and nine~~ months ended ~~December 31,~~June 30, 2022 and 2021 totaled $~~1,087,550~~1,033,363, and $~~3,184,976~~995,334, respectively. ~~Depreciation Expense~~Of these totals, $826,401 and $769,956 were included in cost of goods sold for the three months ending June 30, 2022 and ~~nine months ended December 31, 2020 totaled~~2021. Additionally, $~~731,183~~206,962, and $~~2,110,125~~225,378~~, respectively.~~ were included in depreciation and amortization expenses in operating expenses.

On June 30, 2022, we posted a bond of approximately $1.6 million related to a judgement assessed to GunBroker.com. Per the terms of the Merger Agreement, the Seller is required to pay or be liable for these losses (capitalized terms are defined in Note 14). Accordingly, on August 1, 2022, we received these funds.

On July 1, 2019, we entered into a Factoring and Security Agreement with Factors Southwest, LLC (“FSW”). FSW may purchase from time to time the Company’s Accounts Receivables with recourse on an account by account basis. The twenty-four month agreement contains a maximum advance amount of $5,000,000 on 85% of eligible accounts and has an annualized interest rate of the Prime Rate published from time to time by the Wall Street Journal plus 4.5%. The agreement contains fee of 3% ($150,000) of the Maximum Facility assessed to the Company. Our obligations under this agreement are secured by present and future accounts receivables and related assets, inventory, and equipment. The Company has the right to terminate the agreement, with 30 days written notice, upon obtaining a non-factoring credit facility. This agreement provides the Company with the ability to convert our account receivables into cash. As of ~~December 31, 2021,~~June 30, 2022, the outstanding balance of the Factoring Liability was $~~4,097,867~~228,026. For the three ~~and nine~~ months ended ~~December 31, 2021,~~June 30, 2022, interest expense recognized on the Factoring Liability was $~~103,876~~59,816 ~~and $216,242, respectively,~~ including $37,500 ~~and $75,000~~of ~~respective~~ amortization of the commitment fee and for the three ~~and nine~~ months ended ~~December 31, 2020~~June 30, 2021 was $~~86,006~~41,579 ~~and $313,747, respectively, including $37,500~~ ~~and $50,000~~ ~~of respective amortization of the commitment fee.~~.

On June 17, ~~2020,~~ 2021, this agreement was amended which extended the maturity date to June 17, ~~2022.~~2023.

On June 17, 2020, we entered into a Revolving Inventory Loan and Security Agreement with FSW. FSW will establish a revolving credit line, and make loans from time to time to the Company for the purpose of providing capital. The twenty-four month agreement secured by our inventory, among other assets, contains a maximum loan amount of $1,750,000 on eligible inventory and has an annualized interest rate of the greater of the three-month LIBOR rate plus 3.09% or 8%. The agreement contains a fee of 2% of the maximum loan amount ($35,000) assessed to the Company. On July 31, 2020, the Company amended its Revolving Loan and Security Agreement to increase the maximum inventory loan amount to $2,250,000. As of ~~December 31, 2021,~~June 30, 2022, the outstanding balance of the Inventory Credit Facility was $~~194,810~~92,332. Interest expense recognized on the Inventory Credit Facility was $~~24,256~~5,142 for the three months ended June 30, 2022 and $17,659, including $8,561 of amortization of the annual fee for the ~~nine~~three months ended ~~December 31, 2021 and $118,202, including $24,962~~ ~~of amortization of the annual fee for the nine months ended December 31, 2020.~~June 30, 2021.

We lease office, manufacturing, and warehouse space in Scottsdale, ~~and Payson,~~ AZ, Atlanta and Marietta, GA, and Manitowoc and Two Rivers, WI under contracts we classify as operating leases. None of our leases are financing leases. The ~~Payson lease had an option to renew for~~ ~~five years~~ ~~and the lease expired in November of 2021. The~~ Scottsdale lease does not include a renewal option. ~~As of June 26, 2020, the Company entered into an amended agreement that modified the Manitowoc lease to monthly payments of $34,071~~ ~~and decrease the term to~~ ~~March 2025. The agreement does not contain a renewal option. Accordingly, we modified our Right of Use Assets and Operating Lease Liabilities by $737,680~~ ~~at June 30, 2020.~~ In August of 2021 we extended the lease of our Atlanta offices through May of 2027, accordingly we increased our Right of Use Assets and Operating Lease Liabilities by $501,125 at September 30, 2021. In January of 2022, we extended the lease of our second Manitowoc, WI location and increased our Right of Use Assets and Operating Lease Liabilities by $308,326.

~~Consolidated lease expense~~As of June 30, 2022 and March 31, 2022, total Right of Use Assets were $2,583,344 and $2,791,850, respectively. As of June 30, 2022 and March 31, 2022, total Operating Lease Liabilities were $2,711,698 and $2,922,780, respectively. The current portion of our Operating Lease Liability on June 30, 2022 and March 31, 2022 is $811,139 and $831,429 respectively and is reported as a current liability. The remaining $1,900,559 of the total $2,711,698 for the ~~three~~quarter ended June 30, 2022 and ~~nine months ended December 31, 2021 were~~the $~~309,766~~ 2,091,351~~and~~ of the total $~~896,594~~ 2,922,780~~including $307,278~~ ~~and $882,028~~ ~~of respective operating lease expense and $2,488~~ ~~and $14,566~~ ~~of respective other lease associated expenses such as association dues, taxes. Consolidated lease expense~~ for the ~~three and nine months~~year ended ~~December 2020 was $217,140~~ ~~and $609,250, respectively, including $179,487and $534,781~~ March 31, 2022 of ~~respective operating lease expense and $37,653~~ ~~and $74,468~~ the Operating Lease Liability is presented as a long-term liability net of ~~respective other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals.~~the current portion.

The weighted average remaining lease term and weighted average discount rate for operating leases were ~~3.7~~3.4 years and ~~10.0~~10.0%%, respectively.

Future minimum lease payments under non-cancellable leases as of ~~December 31, 2021~~June 30, 2022 are as follows:

Years Ended March 31,
2022 ⁽¹⁾	$	291,808		$	782,069
2023		1,018,689			992,620
2024		873,420			796,066
2025		675,078			351,962
2026		250,008			257,508
Thereafter		301,168			43,660
Total		3,410,171
Total Lease Payments					3,223,885
Less: Amount Representing Interest		(578,121	)		(512,187	)
Operating lease liability, net	$	2,832,050
Present Value Of Lease Liabilities				$	2,711,698

For the three ~~and nine~~ months ended ~~December 31,~~June 30, 2022 and 2021, the Company made $~~158,131~~165,264 and $~~463,192~~150,755 in ~~respective~~ principal payments, respectively, in connection with the Amended Note B, an amended related party note payable with Jagemann Stamping Company (“JSC”). We entered to the Amended Note B with JSC on November 4, 2020 and the note matures on June 26, 2023. We recognized $~~31,438~~18,652 and $~~94,210~~33,141 in ~~respective~~ interest expenses for the three ~~and nine~~ months ended ~~December 31,~~June 30, 2022 and 2021, respectively.

On October 14, 2021, we entered into a Construction Loan Agreement (the “Loan Agreement”) with Hiawatha National Bank (“Hiawatha”). The Loan Agreement specifies that Hiawatha may lend up to $11,625,000 to the Borrower to pay a portion of the construction costs of an approximately 160,000 square foot manufacturing facility to be constructed our property (the “Loan”). The first advance of Loan funds by Hiawatha was made on October 14, 2021 in the amount of $329,843. We expect to receive further advances of Loan funds approximately every month as our “owner’s equity” is fully funded into the ongoing new plant construction project. The Loan is an advancing term loan and not a revolving loan so any portion of the principal repaid cannot be reborrowed.

Additionally, on October 14, 2021, we issued a Promissory Note in favor of Hiawatha (the “Note”) in the amount of up to $11,625,000 with an interest rate of four and one-half percent (4.5%). The maturity date of the Note is October 14, 2026.

We can prepay the Note in whole or in part starting in July 2022 with a prepayment premium of one percent (1%) of the principal being prepaid.

The Loan Agreement contains customary events of default including, but not limited to, a failure to make any payments pursuant to the Loan Agreement or Note, a failure to complete construction of the project, a lien of $100,000 or more against the property, or a transfer of the property without Hiawatha’s consent. Upon the occurrence of an event of default, among other remedies, the amounts due pursuant to the Loan can be accelerated, Hiawatha can foreclose on the property pursuant to the mortgage, and a late charge of five percent (5%) of the amount due will be owed with all amounts then owed pursuant to the Note bearing interest at an increased rate.

For the three months ended June 30, 2022, approximately $5.8 million of Loan funds were advanced including $1.0 million of cash collateral or restricted cash as security for the Loan. The restricted cash can be released per the terms documented in the Loan Agreement filed with the Commission on Form 10-Q on February 14, 2022.

Our authorized capital consists of 200,000,000 shares of common stock with a par value of $0.001 per share.

During the ~~nine months~~three month period ended ~~December 31, 2021,~~June 30, 2022, we issued ~~22,336,437~~ 438,137shares of common stock as follows:

At ~~December 31, 2021,~~June 30, 2022, outstanding and exercisable stock purchase warrants consisted of the following:

	Number of Shares			Weighted Averaged Exercise Price		Weighted Average Life Remaining (Years)		Number of Shares			Weighted Average Exercise Price		Weighted Average Life Remaining (Years)
Outstanding at March 31, 2021		3,607,945		$	2.31		3.24
Outstanding at March 31, 2022									2,933,755		$	2.32		2.29
Granted		100,000			0.01		4.91		-			-		-
Exercised		(774,190	)		1.99		-		(100,000	)		0.01		4.44
Forfeited or cancelled		-			-		-		-			-		-
Outstanding at December 31, 2021		2,933,755		$	2.32		2.53
Exercisable at December 31, 2021		2,933,755		$	2.32		2.53
Outstanding at June 30, 2022									2,833,755		$	2.40		2.01
Exercisable at June 30, 2022									2,833,755		$	2.40		2.01

As of ~~December 31, 2021,~~June 30, 2022, we had ~~2,933,755~~2,833,755 warrants outstanding. Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase ~~100,000~~ ~~shares of Common Stock at an exercise price of $0.01~~ ~~per share until December 2026, (2) warrants to purchase~~ 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; ~~(3)~~(2) warrants to purchase 1,821,567 shares of our Common Stock at an exercise price of $2.00 per share consisting of 32% of the warrants until August 2024, and 68% until February 2026; ~~(4)~~(3) warrants to purchase 474,966 shares of Common Stock at an exercise price of $2.40 until September 2024; ~~(5)~~(4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025, and ~~(6)~~(5) warrants to purchase 150,000 shares of Common Stock at an exercise price of $6.72 until February 2024.

On May 18, 2021, the Company filed a Certificate of Designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware to establish the preferences, voting powers, limitations as to dividends or other distributions, qualifications, terms and conditions of redemption and other terms and conditions of the Series A Preferred Stock.

The Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”), as to dividend rights and rights as to the distribution of assets upon the Company’s liquidation, dissolution or winding-up, ranks: (1) senior to all classes or series of Common Stock and to all other capital stock issued by the Company expressly designated as ranking junior to the Series A Preferred Stock; (2) on parity with any future class or series of the Company’s capital stock expressly designated as ranking on parity with the Series A Preferred Stock; (3) junior to any future class or series of the Company’s capital stock expressly designated as ranking senior to the Series A Preferred Stock; and (4) junior to all the Company’s existing and future indebtedness.

The Series A Preferred Stock has no stated maturity and is not subject to mandatory redemption or any sinking fund. In the event of the voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the holders of shares for the Series A Preferred Stock are entitled to be paid out of the Company’s assets legally available for distribution to its stockholders (i.e., after satisfaction of all the Company’s liabilities to creditors, if any) an amount equal to $25.00 per share of the Series A Preferred Stock, plus any amount equal to any accumulated and unpaid dividends to the date of payment before any distribution or payment may be made to holders of shares of Common Stock or any other class of or series of the Corporation’s capital stock ranking, as to rights to the distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up, junior to the Series A Preferred Stock.

The Company will pay cumulative cash dividends on the Series A Preferred Stock when, as and if declared by its board of directors (or a duly authorized committee of its board of directors), only out of funds legally available for payment of dividends. Dividends on the Series A Preferred Stock will accrue on the stated amount of $25.00 per share of the Series A Preferred Stock at a rate per annum equal to ~~8.75~~8.75%% (equivalent to $2.1875 per year), payable quarterly in arrears. Dividends on the Series A Preferred Stock declared by our board of directors (or a duly authorized committee of our board of directors) will be payable quarterly in arrears on March 15, June 15, September 15 and December ~~15.~~15.

Generally, the Series A Preferred Stock is not redeemable by the Company prior to May 18, 2026. However, upon a change of control or delisting event (each as defined in the Certificate of Designations), the Company will have a special option to redeem the Series A Preferred Stock for a limited period of time.

On May 19, 2021, we entered into an underwriting agreement (the “Underwriting Agreement”) with Alexander Capital, L.P., as representative of several underwriters (collectively, the “Underwriters”), relating to a firm commitment public offering of 1,097,200 newly issued shares of our ~~8.75%~~8.75% Series A Preferred Stock at a public offering price of $25.00 per share. Under the terms of the Underwriting Agreement, we granted the Underwriters a 45-day option to purchase up to an additional 164,580 shares of Series A Preferred Stock from us. The gross proceeds to us from the sale of 1,097,200 shares of Series A Preferred Stock, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, was $27,430,000. The closing of the offering took place on May 21, 2021.

On May 25, 2021, we entered into an additional underwriting agreement with Alexander Capital, L.P. relating to a firm commitment public offering of 138,220 newly issued shares of our Series A Preferred Stock at a public offering price of $25.00 per share. The closing of the offering took place on May 27, 2021. The gross proceeds to us from the sale of 138,220 shares of Series A Preferred Stock, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, were $3,455,500. Additionally, the Underwriters exercised its previously announced over-allotment option to purchase 164,580 shares of Series A Preferred Stock pursuant to that certain Underwriting Agreement dated May 19, 2021, by and between us and Alexander Capital, L.P., as representative of the several underwriters identified therein. We closed the exercise of the over-allotment option on May 27, 2021. The gross proceeds from the exercise of the over-allotment option were $4,114,500, before deducting underwriting discounts and commissions.

We accumulated $136,061 and $337,745 of Preferred ~~dividends accumulated~~Dividends as of ~~December 31,~~June 30, 2022 and 2021, ~~were $~~respectively.

. On ~~August 27, 2021~~May 12, 2022, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning ~~May 21, 2021 (the first issuance date of the Series A Preferred Stock)~~March 15, 2022 through and including June ~~30, 2021~~14, 2022 payable on ~~September~~June 15, ~~2021~~2022 to holders of record of Series A Preferred Stock on ~~August~~May 31, ~~2021~~2022 equal to $~~0.241246528~~ 0.559027777777778per share. Dividends totaling $~~337,745~~ 782,639were paid on ~~September~~June 15, 2021. On November 17, 2021, the Board of Directors of the Company declared a dividend on the Company’s Series A Preferred Stock for the period beginning July 1, 2021 through and including December 14, 2021 payable on December 15, 2021 to holders of record of Series A Preferred Stock on November 30, 2021 equal to $~~1.01475694444444~~ ~~per share. Dividends totaling $1,420,660~~ ~~were paid on December 15, 2021.~~2022.

On April 30, 2021 (the “Effective Date”) we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (“Sub”), Gemini Direct Investments, LLC, a Nevada limited liability company (“Gemini”), and Steven F. Urvan, an individual (the “Seller”), whereby Sub merged with and into Gemini, with Sub surviving the merger as a wholly owned subsidiary of the Company (the “Merger”). At the time of the Merger, Gemini had nine (9) subsidiaries, all of which are related to Gemini’s ownership of the ~~Gunbroker.com~~GunBroker.com business. ~~Gunbroker.com~~GunBroker.com is an on-line auction marketplace dedicated to firearms, hunting, shooting, and related products. The Merger was completed on the Effective Date.

In consideration of the Merger, on the terms and subject to the conditions set forth in the Merger Agreement, on the Effective Date, (i) the Company assumed and repaid an aggregate amount of indebtedness of Gemini and its subsidiaries equal to $50,000,000 (the “Assumed Indebtedness”); and, (ii) the issued and outstanding membership interests in Gemini (the “Membership Interests”), held by the Seller, automatically converted into the right to receive (A) $50,000,000 (the “Cash Consideration”), and (B) 20,000,000 shares of common stock of the Company, $0.001 par value per share (the “Stock Consideration”).

In connection with the Merger Agreement, the Company and the Seller agreed that the Stock Consideration consisted of: (a) 14,500,000 shares issued without being held in escrow or requiring prior stockholder approval; (b) 4,000,000 shares issued subject to the Pledge and Escrow Agreement; and (c) 1,500,000 shares that will not be issued prior to the Company obtaining stockholder approval for the issuance (the “Additional Securities”).

The total estimated consideration consisted of cash payment of $50,000,000 less $1,350,046 of acquired cash, a working capital adjustment of $2,000,000, debt assumption and repayment upon closing of $50,000,000, contingent consideration of $10,755,000 for 1,500,000 Additional Securities, and 18,500,000 shares of AMMO Inc. Common Stock. The shares were valued at $7.17 per share, the five-day average closing price of the Company’s Common Stock immediately preceding the signing of the binding agreement.

Pursuant to the Merger Agreement, the Company completed a Post-Closing Adjustment following the close of the Merger equal to the Closing Working Capital minus the Estimated Working Capital at closing of the Merger. Accordingly, the Company received a cash payment of $129,114 and adjusted the $2,000,000 Estimated Working Capital Adjustment in the fair value of the consideration transferred to $1,870,886.

In accordance with the acquisition method of accounting for business combinations, the assets acquired, and the liabilities assumed have been recorded at their respective fair values. The consideration in excess of the fair values of assets acquired, and liabilities assumed are recorded as goodwill.

The ~~preliminary~~ fair value of the consideration transferred was valued as of the date of the acquisition as follows:


Cash	$	48,649,954	$	48,649,954
Estimated working capital adjustment		1,870,886
Working capital adjustment				1,870,886
Contingent consideration		10,755,000		10,755,000
Common stock		132,645,000		132,645,000
Assumed debt		50,000,000		50,000,000

Fair value of Patent	$	243,920,840	$	243,920,840

The ~~preliminary~~ allocation for the consideration recorded for the acquisition is as follows:


Accounts receivable, net		$	17,002,362		$	17,002,362
Prepaid expenses			478,963			478,963
Equipment			1,051,980			1,051,980
Deposits			703,389			703,389
Other Intangible assets⁽¹⁾	(1)		146,617,380			146,617,380
Goodwill⁽¹⁾	(1)		90,870,094			90,870,094
Right of use assets - operating leases			612,727			612,727
Accounts payable			(12,514,919	)		(12,514,919	)
Accrued expenses			(196,780	)		(196,780	)
Operating lease liability			(704,356	)		(704,356	)

Total Consideration		$	243,920,840		$	243,920,840

This pro forma results of operations gives effect to the acquisition as if it had occurred April 1, 2021. Material pro forma adjustments include the removal of approximately $1.8 million of interest expenses and debt discount amortization and the addition of approximately $0.9 million depreciation and amortization expenses.

We recorded approximately $1.3 million in transaction costs induring the three ~~and nine~~ months ended ~~December 31,~~June 30, 2021.

The purchase price allocation is preliminary. The preliminary estimated fair value recorded for the acquired assets and liabilities assumed with excess consideration recorded as goodwill represent management’s estimate of fair value and are subject to change when additional information may become available. The purchase price allocation will continue to be preliminary until the Company is able to finalize the allocation. The Company expects to finalize the purchase price allocation within the measurement period, but not more than one year following the closing date of the Merger. The final amounts from the valuation may significantly and materially differ from the preliminary allocation herein.

~~These~~ ~~pro forma results of operations gives effect to the acquisition as if it had occurred on April 1, 2021. Material pro forma adjustments include the removal of approximately $1.8~~ ~~million of interest expenses and debt discount amortization and the addition of approximately $0.9~~ ~~million of depreciation and amortization expenses.~~

~~In the current period,~~During our fiscal year ended March 31, 2022, we recorded $90,870,094 of Goodwill generated from our Merger with Gemini.

Amortization expenses related to our intangible assets for the three ~~and nine~~ months ended ~~December 31,~~June 30, 2022 and 2021 were $~~3,535,805~~3,266,760 and $~~9,593,127, respectively. Amortization expenses related to our intangible assets for the three and nine months ended December 31, 2020 were $492,947~~ ~~and $1,478,841~~2,521,517, respectively.

			December 31, 2021											June 30, 2022
	Life		Licenses			Patent			Other Intangible Assets			Life		Licenses			Patent			Other Intangible Assets
Licensing Agreement – Jesse James		5	$	125,000		$	-		$	-			5	$	125,000		$	-		$	-
Licensing Agreement – Jeff Rann		5		125,000			-			-			5		125,000			-			-
Streak Visual Ammunition patent		11.2		-			950,000			-			11.2		-			950,000			-
SWK patent acquisition		15		-			6,124,005			-			15		-			6,124,005			-
Jagemann Munition Components:
Customer Relationships		3		-			-			1,450,613			3		-			-			1,450,613
Intellectual Property		3		-			-			1,543,548			3		-			-			1,543,548
Tradename		5		-			-			2,152,076			5		-			-			2,152,076
GDI Acquisition:
Tradename		15		-			-			76,532,389			15		-			-			76,532,389
Customer List		10		-			-			65,252,802			10		-			-			65,252,802
Intellectual Property		10		-			-			4,224,442			10		-			-			4,224,442
Other Intangible Assets		5		-			-			607,747			5		-			-			607,747
				250,000			7,074,005			151,763,617					250,000			7,074,005			151,763,617

Accumulated amortization – Licensing Agreements				(245,833	)		-			-					(250,000	)		-			-
Accumulated amortization – Patents				-			(1,424,443	)		-					-			(1,671,153	)		-
Accumulated amortization – Intangible Assets				-			-			(12,110,901	)				-			-			(18,606,624	)
			$	4,167		$	5,649,562		$	139,652,716				$	-		$	5,402,852		$	133,156,993

Annual amortization of intangible assets for the next five fiscal years are as follows:

Years Ended March 31,	Estimates for Fiscal Year		Estimates for Fiscal Year
2022 (1)	$	3,479,832
2023		13,095,215
2023 (1)			$	9,828,455
2024		13,074,489		13,074,489
2025		12,664,775		12,664,775
2026		12,674,904		12,664,775
2027				12,553,355
Thereafter		90,317,230		77,773,996
Annual amortization of intangible assets	$	145,306,445	$	138,559,845

On April 30, 2021, ~~the Company~~we entered into an agreement and plan of merger with Gemini, which, along with its subsidiaries, engages primarily in the operation of an online marketplace dedicated to firearms, hunting, shooting and related ~~products. As~~products, which created a ~~result, at December 31, 2021, our~~second reportable segment. Our Chief Executive Officer reviews financial performance based on our two operating segments as follows:

~~Ammunition generated approximately~~ 73%In the current period, we began the reporting of ~~our revenue in~~ the ~~three~~separate allocation of certain corporate general and ~~nine months ended December 31, 2021, while Marketplace generated approximately~~ 92~~% and~~ 76~~% of our operating income in~~administrative expenses including non-cash stock compensation expense, as such we have updated the ~~three and nine months ended December 31, 2021, respectively.~~prior period disclosure herein. The following tables set forth certain financial information utilized by management to evaluate our operating segments for the interim period presented:

							Ammunition		Marketplace		Corporate and other reconciling items(a)			Total
	For the Three Months Ended December 31, 2021						For the Three Months Ended June 30, 2022
	Ammunition		Marketplace		Total		Ammunition		Marketplace		Corporate and other expenses			Total

Net Revenues	$	47,092,417	$	17,596,769	$	64,689,186	$	44,251,080	$	16,504,946	$	-		$	60,756,026
Cost of Revenues		39,904,811		2,261,509		42,166,320		40,337,015		2,283,349		-			42,620,364
General and administrative expense		5,935,949		2,251,175		8,187,124		3,673,112		2,433,729		3,615,724			9,722,565
Depreciation and amortization		420,077		3,305,844		3,725,921		146,412		3,203,944		-			3,350,356
Income from Operations	$	831,580	$	9,778,241	$	10,609,821	$	94,541	$	8,583,924	$	(3,615,724	)	$	5,062,741

							Ammunition		Marketplace		Corporate and other reconciling items(a)			Total
	For the Nine Months Ended December 31, 2021						For the Three Months Ended June 30, 2021
	Ammunition		Marketplace		Total		Ammunition		Marketplace		Corporate and other expenses			Total

Net Revenues	$	123,521,552	$	46,646,051	$	170,167,603	$	32,204,266	$	12,272,066	$	-		$	44,476,332
Cost of Revenues		96,203,543		6,254,232		102,457,775		23,848,248		1,657,190		-			25,505,438
General and administrative expense		17,745,255		5,400,926		23,146,181		2,877,354		1,002,564		2,799,401			6,679,319
Depreciation and amortization		1,260,064		8,784,930		10,044,994		420,242		2,190,819		-			2,611,061
Income from Operations	$	8,312,690	$	26,205,963	$	34,518,653	$	5,058,422	$	7,421,493	$	(2,799,401	)	$	9,680,514

The income tax provision ~~reflective~~ effective tax rates were ~~13.0~~37.0%% and ~~4.0~~0.0%% for the three ~~and nine~~ months ended ~~December 31, 2021. Our effective tax rates were~~ ~~0.0~~%June 30, 2022 and ~~0.0% for the three and nine months ended December 31, 2020,~~2021, respectively. During the three ~~and nine~~ months ended ~~December 31,~~June 30, 2022 and 2021, ~~and 2020,~~ the effective tax rate differed from the U.S. federal statutory rate primarily due to state income taxes for the three months ended June 30, 2022 and the change in the valuation ~~allowance.~~allowance for the three months ended June 30, 2021. The effective tax rates increased during the three ~~and nine~~ months ended ~~December 31, 2021~~June 30, 2022 compared to the prior year ~~periods~~period due to an increase in income from operations.

The Company has never had an Internal Revenue Service audit; therefore, the tax periods ended December 31, 2016, December 31, 2017, and March 31, 2018, 2019, 2020, 2021, and ~~2021~~2022 are subject to audit.

Furthermore, the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) was signed into law on March 27, 2020. The CARES Act was enacted in response to the COVID-19 pandemic and contains numerous income tax provisions, such as relaxing limitations on the deductibility of interest, technical corrections to tax depreciation methods for qualified improvement property and net operating loss carryback periods.

On August 15, 2022, we announced that our Board of Directors have unanimously approved the spin-off of our manufacturing business into a separate publicly traded company. We expect that this the transaction will be in the form of a distribution to our shareholders of 100% of the stock of the new independent publicly traded company. The distribution is intended to be tax-free to both companies and their shareholders for U.S. federal income tax purposes The marketplace business will remain a part of the Company, operating under a new name and ticker symbol. As of this date, we reasonably anticipate the transaction will be completed in the 2023 calendar year, subject to final approval by our Board of Directors, a Form 10 registration statement being declared effective by the U.S. Securities and Exchange Commission, regulatory approvals and satisfaction of other standard and necessary terms and conditions. There can be no assurance the transaction will be consummated or as concerns the ultimate timing of the proposed transaction.

Subsequent to ~~December 31, 2021, we~~the June 30, 2022, the Company issued ~~90,000~~25,000 shares ~~of Common Stock to~~for employees as compensation for a total value of $87,500~~315,000~~ or $3.50 per share. Additionally, 12,121

~~Board~~ shares were issued pursuant the exercise of ~~Directors Share Repurchase Plan~~

~~On February 7, 2021, our Board~~warrants for a total value of ~~Directors authorized a share repurchase program for up to~~ $~~30.0~~24,242 million dollars of our outstanding Common Stock. Purchases made pursuant to the program will be made from time to time, at the Company’s discretion, in the open market, through privately negotiated transactions or through other manners as permitted by federal securities laws. The timing, manner, price and amount of any repurchases will be determined by the Company and will be subject to economic and market conditions, stock price, applicable legal requirements and other factors. The program is expected to commence following the public disclosure of our 2022 fiscal third quarter financial results and filing of this report on Form 10-Q and may be suspended or discontinued at any time..

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Management’s Discussion and Analysis of Financial Condition and Results of Operations is provided to assist the reader in understanding the results of operations, financial condition, and liquidity through the eyes of our management team. This section should be read in conjunction with other sections of this Quarterly Report, specifically, our Consolidated Financial Statements and Supplementary Data.

This document contains certain “forward-looking statements”. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies, goals and objectives of management for future operations; any statements concerning proposed new products and services or developments thereof; any statements regarding future economic conditions or performance; any statements or belief; and any statements of assumptions underlying any of the foregoing.

Forward looking statements may include the words “may,” “could,” “estimate,” “intend,” “continue,” “believe,” “expect,” or “anticipate,” or other similar words, or the negative thereof. These forward-looking statements present our estimates and assumptions only as of the date of this report. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the dates on which they are made. We do not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the dates they are made. You should, however, consult further disclosures and risk factors we included in the section titled Risk Factors contained herein.

In our filings with the Securities and Exchange Commission, references to “AMMO, Inc.”, “AMMO”, “the Company”, “we,” “us,” “our” and similar terms refer to AMMO, Inc., a Delaware corporate, and its wholly owned consolidated subsidiaries.

Our vision is to modernize the ammunition industry by bringing new technologies to market. We intend to do that through acquisition and application of intellectual property that is unique to the industry and through investing in manufacturing equipment and processes that enable us to compete globally.

Our innovative line of match grade armor piercing (“AP”) ~~and~~, hard armor piercing incendiary (“HAPI”) tactical and ballistically matched (“BMMPR”) rounds are the centerpiece of the Company’s strategy to address the unique needs of the armed forces community. This ammunition was designed around a match grade portfolio of projectiles, that include a solid copper boat tail and armor piercing configuration. The distinction between these rounds and ~~others~~other sold, is that the manufacturing process was engineered to ensure extremely tight tolerances between each projectile manufactured, ensuring for the end user that the ballistic trajectory remains consistent between rounds without regard to the actual configuration or round fired. ~~Our AP and HAPI line are also available with our O.W.L. Technology™.~~ The Company has aligned its manufacturing operations to support the large caliber demand from military personnel, such as the 7.62x39, .300NM, .338 Lapua, 12.7 mm and .50 caliber BMG configurations. On February 2, 2021, we announced that we restarted our improved .50 caliber manufacturing line to address increased market demand and fulfill current orders.

WeThrough JMC, we offer ammunition casings for pistol ammunition through large rifle ammunition. ~~Our casing operations~~Jagemann Munitions Components is backed by decades of manufacturing experience that allows the production of high-quality pistol brass and rifle brass components. ~~Born~~Borne from the automotive industry and refined over time to deliver durable and consistent sporting components, ~~Jagemann™ Casings,~~Jagemann Munition Components™, has become one of the largest brass manufacturers in the country, with the capacity to produce more than 750 million pieces of brass each year with the ability to scale to 1 billion rounds on an annual basis. Proud of its American-made components and capabilities, the Company now has complete control over the manufacturing process. This results in a number of advantages when it comes to the brass that leaves our state-of-the-art facility.

On April 30, 2021, we acquired Gemini ~~Direct Investments, LLC (“Gemini”)~~ and nine of its subsidiaries, all of which are related to Gemini’s ownership of the ~~Gunbroker.com marketplace.~~GunBroker.com business.

GunBroker.com is a large online marketplace dedicated to firearms, hunting, shooting and related products. ~~Aside from merchandise bearing its logo, GunBroker.com currently sells none of the items listed on its website.~~ Third-party sellers list items on the site and federal and state laws govern the sale of firearms and other restricted items. Ownership policies and regulations are followed using licensed firearms dealers as transfer agents.

With our recent addition of the Gunbroker.com marketplace, we aim to further enhance our vision of bringing technologies to the industry. Gunbroker.com is a marketplace that connects millions of buyers and sellers allowing our users to access a daily average of over one million unique items.

The focus for our ~~2022~~2023 fiscal year is to continue to expand our brand presence into the markets identified above and to continue to grow our sales within our targeted markets. We intend to do this through establishing key strategic relationships, enrolling in government procurement programs, establishing relationships with leading law enforcement associations and programs, expanding distributor channels, and revitalized marketing campaigns.

Our financial results for the three ~~and nine~~ months ended ~~December 31, 2021~~June 30, 2022 reflect our newly positioned ~~organization.~~organization as we transition into our new manufacturing facility. We believe that we have hired a strong team of professionals, developed innovative products, and continue to raise capital sufficient to establish our presence as a high-quality ammunition provider and marketplace. We continue to focus on growing our top line revenue, and streamlining our operations, and as a result, we experienced ana 36.6% increase in our ~~gross profit margin~~Net Revenues for the three ~~and nine~~ months ended ~~December 31,~~June 30, 2022 compared with the three months ended June 30, 2021. This was the result of ~~a significant~~production capacity increase, ~~in sales allowing us to cover a greater percentage of our fixed manufacturing costs, which include our non-cash amortization and depreciation expense~~ as well as ~~the addition~~a full quarter of operations for our new marketplace, ~~Gunbroker.com.~~GunBroker.com, in comparison to the prior year period.

The following table presents summarized financial information taken from our condensed consolidated statements of operations for the three ~~and nine months~~ ended ~~December 31, 2021~~June 30, 2022 compared with the three ~~and nine~~ months ended ~~December 31, 2020:~~June 30, 2021:

	For the Three Months Ended						For the Nine Months Ended						For the Three Months Ending
	December 31, 2021			December 31, 2020			December 31, 2021			December 31, 2020			June 30, 2022		June 30, 2021
	(Unaudited)			(Unaudited)			(Unaudited)			(Unaudited)			(Unaudited)		(Unaudited)
Net Sales	$	64,689,186		$	16,620,244		$	170,167,603		$	38,293,086		$	60,756,026	$	44,476,332
Cost of Revenues		42,166,320			13,278,338			102,457,775			32,590,149			42,620,364		25,505,438
Gross Margin		22,522,886			3,341,906			67,709,828			5,702,937
Gross Profit														18,135,662		18,970,894
Sales, General & Administrative Expenses		11,913,045			3,770,713			33,191,175			10,621,873			13,072,921		9,290,380
Income (loss) from Operations		10,609,821			(428,807	)		34,518,653			(4,918,936	)
Income from Operations														5,062,741		9,680,514
Other income (expense)
Other expense		(189,956	)		(1,477,630	)		(446,616	)		(2,429,915	)
Income (loss) before provision for income taxes	$	10,419,865		$	(1,906,437	)	$	34,072,037		$	(7,348,851	)
Other income (expense)														73,011		(143,854	)
Income before provision for income taxes													$	5,135,752	$	9,536,660
Provision for income taxes		1,351,998			-			1,351,998			-			1,882,725		-
Net Income (Loss)	$	9,067,867		$	(1,906,437	)	$	32,720,039		$	(7,348,851	)
Net Income													$	3,253,027	$	9,536,660

We analyze operational and financial data to evaluate our business, allocate our resources, and assess our performance. In addition to total net sales, net loss, and other results under accounting principles generally accepted in the United States (“GAAP”), the following information includes key operating metrics and non-GAAP financial measures we use to evaluate our business. We believe these measures are useful for period-to-period comparisons of the Company. We have included these non-GAAP financial measures in this Quarterly Report on Form 10-Q because they are key measures we use to evaluate our operational performance, produce future strategies for our operations, and make strategic decisions, including those relating to operating expenses and the allocation of our resources. Accordingly, we believe these measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.

	For the Three Months Ended						For the Nine Months Ended						For the Three Months Ended
	31-Dec-21			31-Dec-20			31-Dec-21			31-Dec-20			June 30, 2022			June 30, 2021

Reconciliation of GAAP net income to Adjusted EBITDA
Net Income (Loss)	$	9,067,867		$	(1,906,437	)	$	32,720,039		$	(7,348,851	)
Net Income													$	3,253,027		$	9,536,660
Depreciation and amortization														4,300,123			3,516,851
Provision for income taxes		1,351,998						1,351,998						1,882,725			-
Depreciation and amortization		4,623,355			1,224,130			12,778,103			3,588,966
Loss on purchase		-			-			-			1,000,000
Excise Taxes		3,982,221			1,201,841			10,317,110			2,707,534
Excise taxes														3,712,341			2,397,771
Interest expense, net		190,319			1,938,630			468,404			2,704,315			120,487			165,279
Employee stock awards		1,045,125			240,853			2,898,250			716,589			1,175,063			699,500
Stock grants		65,098			65,455			197,110			213,130			47,844			66,914
Stock for services		4,200			87,500			4,200			87,500
Warrant Issuance		145,508			-			145,508			-
Other income, net		(363	)		(461,000	)		(21,788	)		(274,400	)		(193,498	)		(21,425	)
Contingent consideration fair value		(359,309	)		(30,748	)		(362,753	)		(88,106	)		(1,302	)		(56,638	)
Adjusted EBITDA	$	20,116,019		$	2,360,224		$	60,496,181		$	3,306,677		$	14,296,810		$	16,304,912

Adjusted EBITDA is a non-GAAP financial measure that displays our net income (loss), adjusted to eliminate the effect of certain items as described below.

We have excluded the following non-cash expenses from our non-GAAP financial measures: provision or benefit for income taxes, depreciation and amortization, ~~loss on purchase,~~ share-based or warrant-based compensation expenses, and changes to the contingent consideration fair value. We believe it is useful to exclude these non-cash expenses because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations.

Adjusted EBITDA as a non-GAAP financial measure also excludes other cash interest income and expense, as these items are not components of our core operations.

Non-GAAP financial measures have limitations, should be considered as supplemental in nature and are not meant as a substitute for the related financial information prepared in accordance with GAAP. These limitations include the following:

Because of these limitations, you should consider the non-GAAP financial measures alongside other financial performance measures, including our net loss and our other financial results presented in accordance with GAAP.

The following table shows our net sales by proprietary ammunition versus standard ammunition for the three ~~and nine~~ months ended ~~December 31, 2021~~June 30, 2022 and ~~2020.~~2021. “Proprietary Ammunition” include those lines of ammunition manufactured by our facilities that are sold under the brand names: STREAK VISUAL AMMUNITION™ and Stelth. We define “Standard Ammunition” as non-proprietary ammunition that directly competes with other brand manufacturers. Our “Standard Ammunition” is manufactured within our facility and may also include completed ammunition that has been acquired in the open market for sale to others. Also included in this category is low cost target pistol and rifle ammunition, as well as bulk packaged ammunition manufactured by us using reprocessed brass casings. Ammunition within this product line typically carries lower gross margins.

	For the Three Months Ended				For the Nine Months Ended				For the Three Months Ending
	December 31, 2021		December 31, 2020		December 31, 2021		December 31, 2020		June 30, 2022		June 30, 2021
Proprietary Ammunition	$	3,784,380	$	1,464,202	$	6,228,348	$	4,973,857	$	2,855,934	$	1,110,621
Standard Ammunition		40,285,093		11,370,288		106,401,307		23,013,581		38,113,949		27,241,159
Ammunition Casings		3,022,944		3,785,754		10,891,897		10,305,648		3,281,197		3,852,486
Marketplace Revenue		17,596,769		-		46,646,051		-		16,504,946		12,272,066
Total Sales	$	64,689,186	$	16,620,244	$	170,167,603	$	38,293,086	$	60,756,026	$	44,476,332

Sales for the three ~~and nine~~ months ended ~~December 31, 2021~~June 30, 2022 increased ~~289% and 344%, respectively~~36.6% or approximately ~~$48.1~~$16.3 million, ~~or $132.0 million, respectively~~ over the three ~~and nine~~ months ended ~~December 31, 2020.~~June 30, 2021. This increase was the result of approximately ~~$29.0~~$10.9 million ~~and $83.4 million~~ of ~~respective~~ increased sales in bulk pistol and rifle ammunition, an increase of approximately ~~$2.3~~$1.8 million ~~and $1.3 million~~ of ~~respective~~ sales of Proprietary Ammunition, a decrease of approximately ~~$0.8 million and an increase of approximately~~ $0.6 million of ~~respective~~ sales from our casing operations, and ~~$17.6~~an increase of approximately $4.2 million ~~and $46.6 million in respective~~of revenue generated from our ~~recently acquired~~ marketplace, ~~Gunbroker.com,~~GunBroker.com, which includes auction revenue, payment processing revenue, and shipping income. Management expects the sales growth rate of Proprietary Ammunition to greatly outpace the sales of our Standard Ammunition.

We are focused on continuing to grow top line revenue quarter-over-quarter as we continue to further expand distribution into commercial markets, introduce new product lines, and continue to initiate sales to U.S. law enforcement, military, and international markets.

Through our acquisition of SWK, the Company has developed and deployed a new line of tactical armor piercing (AP) and hard armor piercing incendiary (HAPI) precision ammunition to meet the lethality requirements of both the US and foreign military customers. This line was formally launched at SHOT Show in Las Vegas, where our team demonstrated or presented the capability to more than 15 countries around the world. We continue to demonstrate our AP and HAPI ammunition to military personnel at scheduled and invite only events, resulting in increased interest and procurement discussions. The Company has since developed the ballistic match (BMMPR) and signature-on-target (SoT) rounds under contract with the U.S. Government in support of US special operations which have been publicly announced pursuant to governmental authorization. Additional work continues in support of the military operations of the U.S. and its ally military components which is not currently subject to disclosure.

It is important to note that, although U.S. law enforcement, military and international markets represent significant opportunities for our Company, they also have a long sales cycle. The Company’s sales team has been effective in establishing sales and distribution channels, both in the United States and abroad, which are reasonably anticipated to drive sustained sales opportunity in the military, law enforcement, and commercial markets.

Sales outside of the United States require licenses and approval from either the U.S. Department of Commerce or the U.S. State Department, which typically takes approximately 30 days to receive. On ~~July 21, 2020,~~June 16, 2022, we renewed our annual registration with the International Traffic in Arms Regulations (“ITAR”), which remains valid through the report date. This permits the Company to export and broker ammunition and other controlled items covered under ITAR.

On June 23, 2021, we announced that we were awarded a U.S. Department of Defense contract for the development and manufacture of ballistically matched multi-purpose rounds to design and manufacture multiple Ballistically Matched Multi-Purpose Rounds (BM-MPR) in support of U.S. military operations.

On September 23, 2021, we announced that we were awarded a U.S. Department of Defense contract to design and manufacture signature-on-target rounds (“SoT”) in support of U.S. military operations. The SoT ammunition allows the machine gunner to see bullet impacts without a visible signature in flight exposing their firing location in the manner which occurs with currently utilized tracer ammunition.

Cost of Revenues increased by approximately ~~$28.9 million and $69.9~~$17.1 million from ~~$13.3 million and $32.6~~$25.5 million to ~~$42.2 million and $102.5~~$42.6 million for the three ~~and nine~~ months ended ~~December 31, 2021~~June 30, 2022 compared to the comparable period ended in ~~2020.~~2021. This was the result of a significant increase in net sales as well increases to non-cash depreciation related to increases in production equipment, expensing of increased labor, overhead, and raw materials used to produce finished product during ~~2021~~2022 as compared to ~~2020,~~2021, and additional cost of revenues related to a full quarter of operations from our ~~recent acquisition of our~~ marketplace, ~~Gunbroker.com. As a percentage of sales, cost of goods sold decreased by 18.4% and 29.3 % when comparing~~GunBroker.com, in comparison to the ~~three and nine months ended December 31, 2021 and 2020.~~prior year period.

Our gross margin percentage ~~increased~~decreased to ~~34.8% and 39.8%~~29.8% from ~~20.1% and 14.9%~~42.7% during the three ~~and nine~~ months ended ~~December 31, 2021, respectively,~~June 30, 2022 as compared to the same period in ~~2020. This~~2021. The decrease in our gross margin was ~~a result~~related to increased costs of ~~increased sales allowing us to cover a greater percentage of our fixed manufacturing costs, which include our non-cash amortization~~raw materials, labor, and ~~depreciation expense, and the inclusion of our newly acquired marketplace, Gunbroker.com which, by nature has significantly higher margins than our manufactured products.~~overhead costs.

We believe as we continue to grow sales through new markets and expanded distribution that our gross margins will also increase ~~as evidenced~~ by ~~the improvement over~~efficiencies added through our new production facility scheduled to come online this ~~time last~~fiscal year. Our goal in the next 12 to 24 months is to continue to improve our gross margins. This will be accomplished through the following:

Overall, for the three ~~and nine~~ months ended ~~December 31, 2021,~~June 30, 2022, our operating expenses increased by approximately ~~$8.1 million and $22.6~~$3.8 million over the three ~~and nine~~ months ended ~~December 31, 2020,~~June 30, 2021 and ~~decreased~~increased as a percentage of sales from ~~22.7% and 27.7%~~20.1% for the three ~~and nine~~ months ended ~~December 31, 2020~~June 30, 2021 to ~~18.4% and 19.5%~~21.5% for the three ~~and nine~~ months ended December 31, 2021. The increase was primarily related to approximately $14.2 million of additional operating expenses following our merger with Gemini, including $8.8 million of depreciation and amortization expenses.June 30, 2022. Our operating expenses include non-cash depreciation and amortization expense of approximately ~~$3.7 million and $10.0~~$3.4 million for the three ~~and nine~~ months ended ~~December 31, 2021.~~June 30, 2022. Our operating expenses consisted of commissions related to our sales increases, stock compensation expense associated with issuance of our Common Stock in lieu of cash compensation for employees, ~~and~~ board members, and key consultants for the organization during the period. Operating expenses for the ~~nine~~three months ended ~~December 31, 2021 and 2020 periods~~June 30, 2022 included noncash expenses of approximately ~~$12.9 million and $3.2 million, respectively.~~$4.6 million. We expect to see administrative expenditures ~~to continue to~~ decrease as a percentage of sales in the ~~2022~~2023 fiscal year, as we leverage our work force and expand our sales opportunities.

During the three ~~and nine~~ months ended ~~December 31, 2021,~~June 30, 2022, our selling and marketing expenses increased by approximately ~~$1.0 million and $3.0~~$0.7 million in comparison to the three ~~and nine~~ months ended ~~December 31, 2020.~~June 30, 2021. The increase was primarily related to ~~commissions~~commission on the increases in the sale of our products resulting of approximately ~~$0.7~~$0.4 million ~~and $2.5 million of additional expenses~~ for the three ~~and nine~~ months ended ~~December 31,~~June 30, 2021 in comparison to the comparable prior period, as well as an increase of approximately $0.5 million in advertising and marketing costs for the same period.

Our corporate general & administrative expenses increased approximately ~~$2.1 million and $7.2~~$1.9 million in the three ~~and nine~~ months ended ~~December 31, 2021~~June 30, 2022 from the comparable prior period mainly due to ~~increased general corporate expenses related to~~inclusion of the ~~addition~~full quarter of Gemini expenses for the quarter ended June 30, 2021, as compared to partial inclusion during the quarter ended June 30, 2021, as a result of approximately $1.3 million and $3.3 million, respective increases in insurance expenses of $0.8 million and $1.6 million. and increased professional and legal fees of $0.5 million primarily related to ourthe acquisition ~~of Gemini.~~occurring on April 30, 2021.

Employee salaries and related expenses increased approximately ~~$1.8 million and $4.6~~$0.4 million for the three ~~and nine~~ months ended ~~December 31, 2021~~June 30, 2022 compared to the comparable period ended in ~~2020.~~2021. The increase for the three ~~and nine~~ months ended ~~December 31, 2021~~June 30, 2022 when compared to the prior period was primary related to an increase inof stock compensation of approximately ~~$0.8 million and $2.2 million, respectively.~~$0.5 million.

Depreciation and amortization expenses for the three ~~and nine months~~ ended ~~December 31, 2021~~June 30, 2022 increased by approximately ~~$3.3 million and $8.8~~$0.7 million from the comparable prior ~~periods~~period due to ~~depreciation and amortization expenses~~increases in ~~connection with~~ the ~~acquisition~~carrying value of ~~Gemini.~~equipment.

For the three ~~and nine~~ months ended ~~December 31, 2021,~~June 30, 2022, interest expense decreased by approximately ~~$1.7 million and $2.2~~$0.1 million compared with the comparable three ~~and nine~~ months ended ~~December 31, 2020.~~June 30, 2021. The change from the prior periods was mainly due to the repayment of notes ~~and conversion of convertible promissory notes in current and prior periods.~~during the three months ended June 30, 2021.

For the three ~~and nine~~ months ended ~~December 31, 2021,~~June 30, 2022, we recorded a provision for federal and state income taxes of approximate ~~$1.4~~$1.9 million. There was no provision for federal and state income taxes during the three ~~and nine~~ months ended ~~December 31, 2020.~~June 30, 2021.

~~As a result of increases in revenues from increased production as well as our acquisition of Gemini, we~~We ended the three ~~and nine~~ months ended ~~December 31, 2021~~June 30, 2022 with a net income of approximately ~~$9.1~~$3.2 million ~~and $32.7 million, respectively,~~ compared with a net ~~losses~~income of approximately ~~$1.9 million and $7.3~~$9.5 million for the three ~~and nine~~ months ended ~~December 31, 2020.~~June 30, 2021.

Our goal is to continue to improve our operating results as we focus on increasing sales and controlling our operating expenses.

As of ~~December 31, 2021,~~June 30, 2022, we had ~~$27,414,571~~$20,901,109 of cash and cash equivalents, a decrease of ~~$90,926,900~~$2,380,366 from March 31, ~~2021.~~2022.

	December 31, 2021		March 31, 2021		June 30, 2022		March 31, 2022
Current assets	$	123,474,142	$	145,620,332	$	131,122,718	$	129,691,636
Current liabilities		35,613,312		12,098,493		34,354,389		35,823,311
	$	87,860,830	$	133,521,839	$	96,768,329	$	93,868,325

For the ~~nine~~three months ended ~~December 31, 2021,~~June 30, 2022, net cash ~~used in~~provided by operations totaled approximately ~~$3.6~~$5.2 million. This was primarily the result of net income of approximately ~~$32.7~~$3.3 million, which was offset by increases in our inventories of approximately ~~$30.1~~$5.6 million, increases in deposits of approximately ~~$13.1~~$0.5 million, ~~increases~~decreases in our accounts receivable of approximately ~~$20.7~~$4.2 million, decreases in prepaid expenses of approximately ~~$1.6~~$0.9 million, and ~~increases~~decreases in our accounts payable ~~and accrued liabilities~~ of ~~$7.5 million and $1.3 million, respectively.~~$3.0 million. Non-cash expenses for depreciation and amortization totaled approximately ~~$12.8~~$4.3 million and non-cash expenses for employee stock awards totaled ~~$2.9~~$1.2 million.

For the ~~nine~~three months ended ~~December 31, 2020,~~June 30, 2021, net cash ~~used in~~provided by operations totaled ~~$5.3~~approximately $8.7 million. This was primarily the result of a net ~~loss~~income of ~~$7.3~~approximately $9.5 million, increases in our ~~period end inventories and accounts receivable of $5.1 million and $3.9 million, respectively, increases in~~ accounts payable ~~and accrued liabilities~~ of ~~$1.8~~approximately $7.0 million, ~~and $2.3~~decreases in prepaid expenses of approximately $1.1 million, ~~respectively, and a loss on Jagemann Munition Components of $1.0 million. The cash used in operations were partially offset by the benefit of~~ non-cash expenses for depreciation and amortization of ~~$3.6 million, non-cash interest expensed recognized for the issuance of warrants of $1.3~~approximately $3.5 million, employee stock compensation of approximately $0.7 million, and stock grants totaling ~~$0.2~~approximately $0.1 million. The cash provided by operations were partially offset increases in inventories of approximately $12.1 million.

During the ~~nine~~three months ended ~~December 31, 2021,~~June 30, 2022, we used approximately ~~$63.3~~$5.3 million in net cash for investing activities. Net cash used in investing activities consisted of approximately ~~$50.5 million uses in connection with the merger of Gemini, and approximately $12.9~~$5.3 million related to purchases of production equipment and the construction of our new manufacturing facility in Manitowoc, WI.

During the ~~nine~~three months ended ~~December 31, 2020,~~June 30, 2021, we used ~~$4.5~~approximately $52.2 million in net cash for investing activities. Net cash used in investing activities consisted of approximately $50.7 million used in connection with the merger of Gemini, and approximately $1.6 million related to ~~purchase fixed assets such as~~purchases of production equipment and the construction of our new ~~production equipment.~~manufacturing facility in Manitowoc, WI.

During the ~~nine~~three months ended ~~December~~ June 30, 2022, net cash used in financing activities was approximately $1.3 million. This was the net effect of an approximate $0.7 million reduction in our Inventory Credit Facility, approximately $0.5 million from insurance premium note payments, and generation of approximately $24.7 million from accounts receivable factoring, which was offset by payments of approximately $25.0 million.

During the three months ended June 30, 2021, net cash used in financing activities was approximately ~~$24.0~~$23.8 million. This was the net effect of a $50.0 million payment on debt assumed from Gemini, $35.0 million of proceeds from the sale of our preferred stock net of approximately $3.2 million of issuance costs, approximately ~~$0.9~~$0.5 million was generated from common stock issued for exercised warrants, the $4.0 million repayment of a note payable, and an approximate ~~$0.9~~$0.8 million reduction in our Inventory Credit Facility. Additionally, approximately ~~$86.5~~$23.6 million was generated from accounts receivable factoring, which was offset by payments of approximately ~~$84.2~~$24.4 million.

During the nine months ended December 31, 2020, net cash provided by financing activities was $27.9 million. This was the net effect of $23.6 million of proceeds from the sale of common stock net of $3.3 million of issuance costs, $3.5 million of proceeds from a related party note, $4.0 million of proceeds from a note payable, $2.3 million generated from our Inventory Credit Facility, $2.3 million was generated from common stock issued for exercised warrants, $2.0 million from the issuance of convertible promissory notes, and $1.0 million proceeds from our paycheck protection program notes payable. Additionally, $26.1 million was generated from accounts receivable factoring, which was offset by payments of $25.8 million. $7.2 million of cash was used for payments on related party notes payable, and $0.5 million toward our insurance premium notes payable.

Existing working capital, cash ~~used in~~flow from operations, bank borrowings, and sales of equity and debt securities are expected to be adequate to fund our operations over the next year. Generally, we have financed operations to date through the proceeds of stock sales, bank financings, and related-party notes. These sources have been adequate to fund our recurring cash expenditures including but not limited to our working capital requirements, capital expenditures to expand our operations, debt repayments, and acquisitions. We intend to continue use the aforementioned sources of funding for capital expenditures, debt repayments, share repurchases and any potential acquisitions.

We lease six locations that are used for our offices, production, and warehousing. As of June 30, 2022, we had $3.2 million of fixed lease payment obligations with $1.0 million payable within the next 12 months. Please refer to Note 9 – Leases for additional information.

As of June 30, 2022, we had an outstanding balance on our Related Party Note Payable of approximately $0.7 million, which is due within the next 12 months.

We ~~believe financing~~ will ~~be available, both through conventional financing relationships and through the continued sales~~finance a portion of our ~~Common Stock. However, there is no assurance that such funding will be available on terms acceptable~~new production facility with our Construction Note Payable. We expect to ~~us or at all. We believe that our current cash on hand, coupled with alternative sources of funding, will be sufficient to satisfy intended capital expenditures, potential acquisitions~~make $0.6 million in principal and ~~general liquidity requirements through at least~~interest payments within the next ~~twelve~~12 months. The total principal balance of the Construction Note is expected to be $11.6 million upon completion of the project and will mature on October 14, 2026.

As of ~~December 31, 2021,~~June 30, 2022, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, net sales, expenses, results of operations, liquidity capital expenditures, or capital resources.

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affected the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the condensed consolidated financial statements include the valuation of allowances for doubtful accounts, valuation of deferred tax assets, inventories, useful lives of assets, goodwill, intangible assets, and stock-based compensation. A summary of our critical accounting policies is included in our Annual Report on Form 10-K for the year ended March 31, ~~2021,~~2022, under “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” There have been no significant changes to these policies during the ~~nine~~three months ended ~~December 31, 2021.~~June 30, 2022. For disclosure regarding recent accounting pronouncements and the anticipated impact they will have on our operations, please refer to Note 2 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended March 31, ~~2021.~~2022.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. We carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of ~~December 31, 2021.~~June 30, 2022. Based on the evaluation of these disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded our disclosure controls and procedures were not effective. Our controls were ineffective due to the size of the Company and available resources. There are limited personnel to assist with the accounting and financial reporting function, which results in: (i) a lack of segregation of duties and (ii) controls that may not be adequately designed or operating effectively. Despite the existence of material weaknesses, the Company believes the financial information presented herein is materially correct and fairly presents the financial position and operating results of the three ~~and nine~~ months ended ~~December 31, 2021,~~June 30, 2022, in accordance with GAAP.

There were no changes in our internal control over financial reporting, as defined in Rule 13a-15(f) promulgated under the Exchange Act, during the ~~Quarterly periods~~quarterly period from April 1, ~~2021~~2022 to ~~December 31, 2021,~~June 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

We are involved in or subject to, or may become involved in or subject to, routine litigation, claims, disputes, proceedings, and investigations in the ordinary course of business. While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position, results of operations or cash flows. We record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.

Please reference the Contingencies section of Note 2 of our Financial Statements for additional disclosure.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

The authorized capital of the Company is 200,000,000 shares of Common Stock with a par value of $0.001 per share and 10,000,000 shares of Preferred Stock with a $0.001 par value per share.

There were no unregistered sales of the Company’s equity securities during the quarter ended ~~December 31, 2021~~June 30, 2022 that were not previously reported in a Current Report on Form 8-K except as follows:

~~During the quarterly period from October 1, 2021 to December 31, 2021, the Company~~We issued ~~1.5 million~~99,762 shares of ~~unregistered~~our Common Stock ~~related to~~issued in accordance with the ~~Merger Agreement with Gemini~~cashless exercise of a warrant for ~~$7.17 per share or~~ a total value of ~~$10,755,000.~~$496,043.

The previously mentioned securities were issued in reliance on the exemptions from registration under the Securities Act in Section 4(a)(2) of the Securities Act and/or Regulation D thereunder.

In accordance with Section 13 or 15(d) of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~December 31, 2021~~June 30, 2022

OR

☐	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Large accelerated filer ☐		Accelerated filer ☐
Non-accelerated filer ☒		Smaller reporting company ☒
Emerging growth company ☐

PART I

ITEM 1:	FINANCIAL STATEMENTS	3
	Condensed Consolidated Balance Sheets as of ~~December 31, 2021~~June 30, 2022 (Unaudited) and March 31, ~~2021~~2022	3
	Condensed Consolidated Statements of Operations (Unaudited) for the three ~~and nine~~ months ended ~~December 31,~~June 30, 2022, and 2021 ~~and 2020~~	4
	Condensed Consolidated Statement of Shareholders’ Equity (Unaudited) for the three ~~and nine~~ months ended ~~December 31,~~June 30, 2022, and 2021 ~~and 2020~~	5
	Condensed Consolidated Statements of Cash flow (Unaudited) for the ~~nine~~three months ended ~~December 31,~~June 30, 2022, and 2021 ~~and 2020~~	6
	Notes to Condensed Consolidated Financial Statements (Unaudited)	8
ITEM 2:	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION	25
ITEM 3:	QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK	33
ITEM 4:	CONTROLS AND PROCEDURES	33

PART II
ITEM 1:	LEGAL PROCEEDINGS	34
ITEM 1A:	RISK FACTORS	34
ITEM 2:	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	34
ITEM 3:	DEFAULTS UPON SENIOR SECURITIES	34
ITEM 4:	MINE SAFETY DISCLOSURE	34
ITEM 5:	OTHER INFORMATION	35
ITEM 6:	EXHIBITS	35
SIGNATURES		36


	Preferred Stock				Common Shares				Additional			Stock
	Number		Par Value		Number		Par Value		Paid-In Capital			Subscription Receivable			Accumulated (Deficit)			Total

Balance as of March 31, 2021		-	$	-		93,099,967	$	93,100	$	202,073,968		$	-		$	(41,819,539	)	$	160,347,529

Acquisition stock issuances		-		-		20,000,000		20,000		142,671,282			-			-			142,691,282
Common stock issued for cash
Common stock issued for cash,shares
Common stock issued for convertible notes
Common stock issued for convertible notes,shares
Stock subscription receivable for exercised warrants
Stock subscription receivable for exercised warrants, Shares
Common stock issued for debt conversion - related party
Common stock issued for debt conversion - related party, Shares
Common stock issuance costs
Issuance of warrants for convertible notes
Common stock issued for covertible notes
Common stock issued for covertible notes, Shares
Common stock issued for debt conversion
Common stock issued for debt conversion, Shares
Issurance of warrants for convertible notes
Common stock issued for exercised warrants		-		-		431,080		431		943,476			-			-			943,907
Common stock issued for cashless warrant exercise		-		-		276,907		277		(277	)		-			-			-
Common stock issued for services and equipment		-		-		772,450		773		1,630,928			-			-			1,631,701
Employee stock awards		-		-		856,000		856		2,897,394			-			-			2,898,250
Stock grants		-		-		-		-		197,110			-			-			197,110
Issuance of Series A Preferred Stock, net of issuance costs		1,400,000		1,400		-		-		31,007,396			-			-			31,008,796
Warrant issued for services										594,033			-			-			594,033
Preferred stock dividends declared		-		-		-		-		-			-			(1,758,405	)		(1,758,405	)
Dividends accumulated on preferred stock		-		-		-		-		-			-			(144,561	)		(144,561	)
Net income		-		-		-		-		-			-			32,720,039			32,720,039

Balance as of December 31, 2021		1,400,000	$	1,400		115,436,404	$	115,437	$	382,015,310		$	-		$	(11,002,466	)	$	371,129,681

Balance as of March 31, 2020		-	$	-		46,204,139	$	46,204	$	53,219,834		$	-		$	(34,007,245	)	$	19,258,793

Common stock issued for cash		-		-		11,536,143		11,537		23,601,082			-			-			23,612,619
Common stock issued for convertible notes		-		-		2,667,358		2,667		3,872,292			-			-			3,874,959
Common stock issued for exercised warrants		-		-		1,096,939		1,097		2,287,781			-			-			2,288,878
Stock subscription receivable for exercised warrants		-		-		309,775		310		664,665			(664,975	)		-			-
Common stock issued for debt conversion - related party		-		-		1,000,000		1,000		2,099,000			-			-			2,100,000
Common stock issued for cashless warrant exercise		-		-		160,274		160		(160	)		-			-			-
Common stock issuance costs		-		-		-		-		(3,344,436	)		-			-			(3,344,436	)
Common stock issued for services		-		-		58,336		58		87,442			-			-			87,500
Employee stock awards		-		-		465,081		465		716,124			-			-			716,589
Stock grants		-		-		-		-		213,130			-			-			213,130
Issuance of warrants for convertible notes		-		-		-		-		1,315,494			-			-			1,315,494
Net loss		-		-		-		-		-			-			(7,348,851	)		(7,348,851	)

Balance as of December 31, 2020		-	$	-		63,498,045	$	63,498	$	84,732,248		$	(664,975	)	$	(41,356,096	)	$	42,774,675

	Preferred Stock				Common Shares				Additional			Stock
	Number		Par Value		Number		Par Value		Paid-In Capital			Subscription Receivable			Accumulated (Deficit)			Total

Balance as of September 30, 2021		1,400,000	$	1,400		113,583,016	$	113,583	$	369,431,456		$	-		$	(19,287,751	)	$	350,258,688

Acquisition stock issuances		-		-		1,500,000		1,500		10,753,500			-			-			10,755,000
Common stock issued for exercised warrants		-		-		50,938		51		122,200			-			-			122,251
Common stock issued for cashless warrant exercise		-		-		-		-		-			-			-			-
Common stock issued for services and equipment		-		-		1,200		2		4,198			-			-			4,200
Employee stock awards		-		-		301,250		301		1,044,824			-			-			1,045,125
Stock grants		-		-		-		-		65,098			-			-			65,098
Warrant issued for services										594,033			-			-			594,033
Issuance of Series A Preferred Stock, net of issuance costs		-		-		-		-		-			-			-			-
Preferred stock dividends declared		-		-		-		-		-			-			(638,021	)		(638,021	)
Dividends accumulated on preferred stock		-		-		-		-		-			-			(144,561	)		(144,561	)
Net income		-		-		-		-		-			-			9,067,867			9,067,867

Balance as of December 31, 2021		1,400,000	$	1,400		115,436,404	$	115,437	$	382,015,310		$	-		$	(11,002,466	)	$	371,129,681

Balance as of September 30, 2020		-	$	-		48,324,347	$	48,323	$	56,895,422		$	-		$	(39,449,659	)	$	17,494,086

Common stock issued for cash		-		-		9,872,928		9,873		20,720,875			-			-			20,730,748
Common stock issued for convertible notes		-		-		2,667,358		2,667		3,872,292			-			-			3,874,959
Common stock issued for exercised warrants						975,726		977		2,045,476			-			-			2,046,453
Stock subscription receivable for exercised warrants						309,775		310		664,665			(664,975	)		-			-
Common stock issued for debt conversion						1,000,000		1,000		2,099,000			-			-			2,100,000
Common stock issued for cashless warrant exercise						159,995		160		(160	)		-			-			-
Common stock issuance costs		-		-		-		-		(3,274,436	)		-			-			(3,274,436	)
Common stock issued for services						50,000		50		87,450			-			-			87,500
Employee stock awards		-		-		137,916		138		240,715			-			-			240,853
Stock grants		-		-		-		-		65,455			-			-			65,455
Issuance of warrants for convertible notes		-		-		-		-		1,315,494			-			-			1,315,494
Net loss		-		-		-		-		-			-			(1,906,437	)		(1,906,437	)
Net Income(loss)		-		-		-		-		-			-			(1,906,437	)		(1,906,437	)

Balance as of December 31, 2020		-	$	-		63,498,045	$	63,498	$	84,732,248		$	(664,975	)	$	(41,356,096	)	$	42,774,675

	Number		Par Value		Number		Par Value		Paid-In Capital			Accumulated (Deficit)			Total
	Preferred Stock				Common Shares				Additional
			Par				Par		Paid-In			Accumulated
	Number		Value		Number		Value		Capital			(Deficit)			Total

Balance as of March 31, 2022		1,400,000	$	1,400		116,485,747	$	116,487	$	385,426,431		$	(11,240,752	)	$	374,303,566

Common stock issued for cashless warrant exercise		-		-		99,762		99		(99	)		-			-
Employee stock awards		-		-		338,375		338		1,174,725			-			1,175,063
Stock grants		-		-		-		-		47,844			-			47,844
Preferred stock dividends declared													(638,071	)		(638,071	)
Dividends accumulated on preferred stock		-		-		-		-		-			(136,061	)		(136,061	)
Net income		-		-		-		-		-			3,253,027			3,253,027

Balance as of June 30, 2022		1,400,000	$	1,400		116,923,884	$	116,924	$	386,648,901		$	(8,761,857	)	$	378,005,368

Balance as of March 31, 2021		-	$	-		93,099,967	$	93,100	$	202,073,968		$	(41,819,539	)	$	160,347,529
Balance		-	$	-		93,099,967	$	93,100	$	202,073,968		$	(41,819,539	)	$	160,347,529

Acquisition stock issuances		-		-		18,500,000		18,500		131,947,282			-			131,965,782
Common stock issued for exercised warrants		-		-		219,144		219		477,592			-			477,811
Common stock issued for cashless warrant exercise		-		-		275,155		275		(275	)		-			-
Common stock issued for services		-		-		750,000		750		1,499,250			-			1,500,000
Employee stock awards		-		-		202,500		203		699,297			-			699,500
Stock grants		-		-		-		-		66,914			-			66,914
Issuance of Series A Preferred Stock, net of issuance costs		1,400,000		1,400		-		-		31,007,396			-			31,008,796
Dividends accumulated on preferred stock		-		-		-		-		-			(337,745	)		(337,745	)
Net income		-		-		-		-		-			9,536,660			9,536,660

Balance as of June 30, 2021		1,400,000	$	1,400		113,046,766	$	113,047	$	367,771,424		$	(32,620,624	)	$	335,265,247
Balance		1,400,000	$	1,400		113,046,766	$	113,047	$	367,771,424		$	(32,620,624	)	$	335,265,247

	●	Identification of a contract with a customer
	●	Identification of the performance obligations in the contact
	●	Determination of the transaction price
	●	Allocation of the transaction price to the separate performance allocation
	●	Recognition of revenue when performance obligations are satisfied

	●	~~20,000,000~~ ~~shares were issued in connection with our merger of Gemini Direct Investments, LLC valued at $142,691,282~~
	●	~~431,080~~ ~~shares were issued to investors for exercised warrants valued for $943,907~~
	●	~~276,907~~99,762 shares were issued for cashless exercise of ~~343,110~~100,000 warrants
	●	~~772,450~~338,375 shares valued at $~~1,631,701~~ ~~were issued for services and equipment provided to the Company~~
	●	~~856,000~~ ~~shares valued at $2,898,250~~1,175,063 were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation

INCOME STATEMENT DATA	For the Three Months Ended June 30, 2021

Net revenues	$	52,521,753
Net income	$	14,083,148

INCOME STATEMENT DATA	For the Nine Months Ended December 31, 2021

Net revenues	$	178,213,024
Net income	$	37,266,527

	●	Ammunition – which consists of our manufacturing business. The Ammunition segment engages in the design, production and marketing of ammunition and ammunition component products.
	●	Marketplace – which consists of the GunBroker.com marketplace. In its role as an auction site, GunBroker.com supports the lawful sale of firearms, ammunition and hunting/shooting accessories.

	●	Employee stock awards and stock grants expense has been, and will continue to be for the foreseeable future, a significant recurring expense in the Company and an important part of our compensation strategy;
	●	the assets being depreciated or amortized may have to be replaced in the future, and the non-GAAP financial measures do not reflect cash capital expenditure requirements for such replacements or for new capital expenditures or other capital commitments; and
	●	non-GAAP measures do not reflect changes in, or cash requirements for, our working capital needs
	●	other companies, including companies in our industry, may calculate the non-GAAP financial measures differently or not at all, which reduces their usefulness as comparative measures.

	●	Increased product sales, specifically of proprietary lines of ammunition, like the STREAK VISUAL AMMUNITION™, Stelth and now our tactical Armor Piercing (AP) and Hard Armor Piercing Incendiary (HAPI) precision ammunition, all of which carry higher margins as a percentage of their selling price;

	●	Introduction of new lines of ammunition that historically carry higher margins in the consumer and government sectors;

	●	~~Leverage~~Reduced component costs through operation of our ~~newly acquired marketplace, Gunbroker.com, through the introduction~~ammunition segment and expansion of ~~additional services and product offerings;~~strategic relationships with component providers;

	●	Expanded use of automation equipment that reduces the total labor required to assemble finished products;

	●	And, better leverage of our fixed costs through expanded production to support the sales objectives.

Exhibit No.		Exhibit

4.1*		~~Promissory Note issued by Ammo, Inc., Firelight Group I, LLC in favor of Hiawatha National Bank, dated October 14, 2021.~~
10.1*		~~Construction Loan Agreement by and among Ammo, Inc., Firelight Group I, LLC, and Hiawatha National Bank, dated October 14, 2021.~~
31.1*		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Fred W. Wagenhals.
31.2*		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Rob Wiley.
32.1**		Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Fred W. Wagenhals.
32.2**		Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Rob Wiley.

101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

	AMMO, INC.

		/s/ Fred W. Wagenhals
Dated: ~~February 14,~~August 15, 2022	By:	Fred W. Wagenhals, Chief Executive Officer

		/s/ Robert D. Wiley
Dated: ~~February 14,~~August 15, 2022	By:	Robert D. Wiley, Chief Financial Officer